<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Genet</journal-id><journal-id journal-id-type="iso-abbrev">Front Genet</journal-id><journal-id journal-id-type="publisher-id">Front. Genet.</journal-id><journal-title-group><journal-title>Frontiers in Genetics</journal-title></journal-title-group><issn pub-type="epub">1664-8021</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7136475</article-id><article-id pub-id-type="doi">10.3389/fgene.2020.00226</article-id><article-categories><subj-group subj-group-type="heading"><subject>Genetics</subject><subj-group><subject>Review</subject></subj-group></subj-group></article-categories><title-group><article-title>Translation-Targeting RiPPs and Where to Find Them</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Travin</surname><given-names>Dmitrii Y.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="corresp" rid="c001"><sup>*</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/849440/overview"/></contrib><contrib contrib-type="author"><name><surname>Bikmetov</surname><given-names>Dmitry</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff4"><sup>4</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/850914/overview"/></contrib><contrib contrib-type="author"><name><surname>Severinov</surname><given-names>Konstantin</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff4"><sup>4</sup></xref><xref ref-type="aff" rid="aff5"><sup>5</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/296621/overview"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Center of Life Sciences, Skolkovo Institute of Science and Technology</institution>, <addr-line>Moscow</addr-line>, <country>Russia</country></aff><aff id="aff2"><sup>2</sup><institution>Institute of Gene Biology, Russian Academy of Sciences</institution>, <addr-line>Moscow</addr-line>, <country>Russia</country></aff><aff id="aff3"><sup>3</sup><institution>Institute of Molecular Genetics, Russian Academy of Sciences</institution>, <addr-line>Moscow</addr-line>, <country>Russia</country></aff><aff id="aff4"><sup>4</sup><institution>Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Institute of Gene Biology, Russian Academy of Sciences</institution>, <addr-line>Moscow</addr-line>, <country>Russia</country></aff><aff id="aff5"><sup>5</sup><institution>Waksman Institute for Microbiology, Rutgers</institution>, <addr-line>Piscataway, NJ</addr-line>, <country>United States</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Michael Ibba, The Ohio State University, United States</p></fn><fn fn-type="edited-by"><p>Reviewed by: Matthieu Gagnon, The University of Texas Medical Branch at Galveston, United States; Jesko K&#x000f6;hnke, Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS), Germany</p></fn><corresp id="c001">*Correspondence: Dmitrii Y. Travin, <email>dmitrii.travin@skoltech.ru</email></corresp><fn fn-type="other" id="fn004"><p>This article was submitted to RNA, a section of the journal Frontiers in Genetics</p></fn></author-notes><pub-date pub-type="epub"><day>31</day><month>3</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>11</volume><elocation-id>226</elocation-id><history><date date-type="received"><day>16</day><month>11</month><year>2019</year></date><date date-type="accepted"><day>26</day><month>2</month><year>2020</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2020 Travin, Bikmetov and Severinov.</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Travin, Bikmetov and Severinov</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p>Prokaryotic translation is among the major targets of diverse natural products with antibacterial activity including several classes of clinically relevant antibiotics. In this review, we summarize the information about the structure, biosynthesis, and modes of action of translation inhibiting ribosomally synthesized and post-translationally modified peptides (RiPPs). Azol(in)e-containing RiPPs are known to target translation, and several new compounds inhibiting the ribosome have been characterized recently. We performed a systematic search for biosynthetic gene clusters (BGCs) of azol(in)e-containing RiPPs. This search uncovered several groups of clusters that likely direct the synthesis of novel compounds, some of which may be targeting the ribosome.</p></abstract><kwd-group><kwd>RiPPs</kwd><kwd>ribosome</kwd><kwd>antibiotics</kwd><kwd>LAPs</kwd><kwd>YcaO</kwd><kwd>azol(in)e-modified peptides</kwd><kwd>genome mining</kwd></kwd-group><funding-group><award-group><funding-source id="cn001">Russian Science Foundation<named-content content-type="fundref-id">10.13039/501100006769</named-content></funding-source><award-id rid="cn001">19-14-00266</award-id></award-group></funding-group><counts><fig-count count="8"/><table-count count="0"/><equation-count count="0"/><ref-count count="99"/><page-count count="16"/><word-count count="0"/></counts></article-meta></front><body><sec id="S1"><title>Introduction</title><p>Antibiotics are extensively used worldwide in healthcare, agriculture, and food preservation. However, development and the spread of resistance to most antibiotics discovered during the second half of the 20th century in the course of the so-called &#x0201c;golden era of antibiotics&#x0201d; has become a global threat (<xref rid="B9" ref-type="bibr">Brown and Wright, 2016</xref>). With multinational pharmaceutical corporations exiting the field, the search for novel natural products, which remain a major source of novel bioactive compounds including antibiotics (<xref rid="B50" ref-type="bibr">Li and Vederas, 2009</xref>; <xref rid="B61" ref-type="bibr">Moloney, 2016</xref>), is largely concentrated in academia and small companies (<xref rid="B96" ref-type="bibr">Wright, 2017</xref>). Classical activity-based strain screening approaches, which are costly and which often result in a rediscovery of the already known compounds, are giving way to &#x0201c;smarter&#x0201d; techniques (<xref rid="B6" ref-type="bibr">Baltz, 2019</xref>). The genome mining approach relies on a &#x0201c;from genes to products&#x0201d; paradigm, which is the opposite of conventional activity-based antibiotic searches, and critically depends on the rapid accumulation of genomic data in publicly available databases (<xref rid="B99" ref-type="bibr">Ziemert et al., 2016</xref>).</p><p>Genome mining for novel metabolites begins with <italic>in silico</italic> predictions of functions of the groups of genes called &#x0201c;biosynthetic gene clusters&#x0201d; (BGCs), whose products may take part in the biosynthesis of a certain metabolite. Making specific predictions about the structure of the final compound enables better prioritizing of candidate BGCs for subsequent time-consuming downstream experimental validation. Both proteinogenic and non-proteinogenic amino acids can act as building blocks for the production of specialized metabolites, leading to a great diversity of naturally occurring bioactive peptides. Peptide natural products originating from bacteria and fungi and currently used as antibiotics are dominated by non-ribosomal peptides (NRPs), assembled by large multisubunit enzymatic complexes (<xref rid="B87" ref-type="bibr">S&#x000fc;ssmuth and Mainz, 2017</xref>). With the number of known NRP BGCs steadily growing, our abilities to predict both the amino acid sequence and tailoring modifications of final compounds based on the sequences of NRP synthases and additional enzymes encoded in BGCs improve as well; however, the complete &#x0201c;nonribosomal code&#x0201d; is not yet known (<xref rid="B1" ref-type="bibr">Ackerley et al., 2016</xref>).</p><p>In addition to NRPs, ribosomally synthesized and post-translationally modified peptides (RiPPs) comprise another rapidly expanding class of bioactive peptides. They are produced by posttranslational modifications (PTMs) of ribosomally synthesized precursors by dedicated enzyme machinery (<xref rid="B4" ref-type="bibr">Arnison et al., 2013</xref>). Compared to those of NRPs, RiPP BGCs are generally smaller and contain a precursor peptide gene, which enables better prediction of the final product structure based not only on the properties of enzymes involved in biosynthesis but also on the chemical structure of the initial peptide substrate. While the number of identified RiPPs grows, there is still an enormous space for the discovery of new compounds expanding the diversity within the already known RiPP subclasses and of entirely new groups of RiPPs harboring novel modifications, as evidenced, for example, by the recently described ranthipeptides (<xref rid="B39" ref-type="bibr">Hudson et al., 2019</xref>) and streptide-like RiPPs (<xref rid="B77" ref-type="bibr">Schramma et al., 2015</xref>).</p><p>Among the RiPPs exhibiting antibacterial activity, there are examples of compounds targeting various validated drug targets, including bacterial RNA polymerase (microcin J25; <xref rid="B18" ref-type="bibr">Delgado et al., 2001</xref>), DNA gyrase [microcin B17 (McB); <xref rid="B36" ref-type="bibr">Heddle et al., 2001</xref>], and the cell membrane (lanthibiotics; <xref rid="B12" ref-type="bibr">Chatterjee et al., 2005</xref>). The prokaryotic ribosome, another key target of many antibiotics currently in use (reviewed in <xref rid="B95" ref-type="bibr">Wilson, 2014</xref>; <xref rid="B72" ref-type="bibr">Polikanov et al., 2018</xref>), is also inhibited by certain RiPPs. In addition to RiPPs directly interacting with the ribosome, there are those that block translation by binding to elongation factors or inhibiting the activity of aminoacyl-tRNA synthetases. In this review, we briefly summarize the available data on the structure, biosynthesis, mode of action, and BGC composition of the known RiPPs inhibiting different steps of translation (<xref ref-type="fig" rid="F1">Figure 1</xref>). In addition, we specifically explore the genomic landscape of azol(in)e-containing RiPPs in an attempt to predict novel RiPPs inhibiting translation. Although definitive predictions of the compound mode of action based entirely on the genomic data can be made only in rare cases (see, for example, the self-resistance guided identification of new topoisomerase inhibitors; <xref rid="B70" ref-type="bibr">Panter et al., 2018</xref>), the results of our search define new subclasses of azol(in)e-containing RiPPs, which may include the translation inhibitors.</p><fig id="F1" position="float"><label>FIGURE 1</label><caption><p>Overview of the prokaryotic translation process and its steps targeted by various RiPPs. IFs&#x02014;initiation factors, RF&#x02014;release factor, aa&#x02014;amino acid, aa-tRNA&#x02014;aminoacyl tRNA, f-Met tRNA&#x02014;initiator N-formylmethionine tRNA.</p></caption><graphic xlink:href="fgene-11-00226-g001"/></fig><sec id="S1.SS1"><title>Thiopeptides</title><p>Thiopeptides comprise one of the best-studied subclasses of RiPPs, with more than 100 compounds characterized to date. Produced predominantly by <italic>Actinobacteria</italic>, they demonstrate various activities including antibacterial and antiplasmoidal (<xref rid="B27" ref-type="bibr">Gaillard et al., 2016</xref>), which result from their ability to inhibit translation by the prokaryotic ribosome and the ribosome within the apicoplast of the malaria parasite <italic>Plasmodium falciparum</italic> (<xref rid="B14" ref-type="bibr">Clough et al., 1997</xref>). All known thiopeptides have the specific set of biosynthetic genes in their BGCs (<xref ref-type="fig" rid="F2">Figure 2A</xref>), share common structural features (<xref ref-type="fig" rid="F2">Figure 2B</xref>), and use two major mechanisms for translation inhibition: they either interact directly with the ribosome (<xref ref-type="fig" rid="F2">Figure 2C</xref>) or prevent the binding of aminoacyl-tRNA by the elongation factor EF-Tu (<xref ref-type="fig" rid="F2">Figure 2D</xref>).</p><fig id="F2" position="float"><label>FIGURE 2</label><caption><p>Thiopeptides. <bold>(A)</bold> Biosynthetic gene clusters of lactazole (a minimal thiopeptide-encoding BGC), nosiheptide, and GE2270A. Functions of encoded proteins are listed on the right. <bold>(B)</bold> Chemical structures of lactazole, nosiheptide, and GE2270A. Azol(in)e cycles are shown in red, six-membered central azacycles in green, dehydrated amino acids in pink, and methylindole acid-containing second ring system of nosiheptide in blue. Auxiliary tailoring modifications are highlighted with gray background. The number of atoms and amino acid residues in the macrocyclic system is indicated for each compound. Macrocycles are shown in bold. Red dashed polygons show conserved residues characteristic for ribosome targeting (nosiheptide) and EF-Tu targeting (GE2270A) thiopeptides. <bold>(C)</bold> Mode of nosiheptide and thiostrepton interaction with the ribosome (PDB IDs 2ZJP and 3CF5; <xref rid="B34" ref-type="bibr">Harms et al., 2008</xref>). Nosiheptide is yellow, thiostrepton is green, uL11 ribosomal protein CTD (C-terminal domain) is lightblue, NTD (N-terminal domain)&#x02014;blue, H43 and H44 helices of 23S rRNA are orange, residues A1067 and A1095 (<italic>E. coli</italic> nomenculature), involved in the rRNA-antibiotic interaction are shown as sticks. <bold>(D)</bold> Mode of action of GE2770A. Elongation factor EF-Tu (blue) is shown in complex with aminoacyl tRNA (aa-tRNA, orange) and GE2270A (yellow) (PDB IDs 1B23 and 2C77, respectively, <xref rid="B63" ref-type="bibr">Nissen et al., 1999</xref>; <xref rid="B71" ref-type="bibr">Parmeggiani et al., 2006</xref>). The binding of GE2270A prevents the interaction of EF-Tu with aa-tRNA acceptor stem.</p></caption><graphic xlink:href="fgene-11-00226-g002"/></fig><p>The first group of thiopeptides is characterized by the small size of a macrocycle (26 atoms) and a conserved region (<xref ref-type="fig" rid="F2">Figure 2B</xref>, nosiheptide, red dashed frame) essential for the interaction with their binding site on the large ribosome subunit, GTP-ase associated center (GAC). Thiostrepton, nosiheptide, and micrococcin, all belonging to this group, were co-crystallized with the large ribosome subunit of <italic>Deinococcus radiodurans</italic>. While most ribosome-targeting antibiotics contact only rRNA, these thiopeptides interact with both rRNA and ribosomal proteins, binding in a cleft formed by the N-terminal domain of the ribosomal protein uL11 and the loops of helices H43 and H44 of the 23S rRNA (<xref ref-type="fig" rid="F2">Figure 2C</xref>; <xref rid="B34" ref-type="bibr">Harms et al., 2008</xref>). Their binding site overlaps with the binding sites of IF2, EF-G, and EF-Tu. Consistently, thiopeptides inhibit initiation (<xref rid="B8" ref-type="bibr">Brandi et al., 2004</xref>), translocation (<xref rid="B74" ref-type="bibr">Rodnina et al., 1999</xref>), and tRNA delivery to the ribosome (<xref rid="B31" ref-type="bibr">Gonzalez et al., 2007</xref>). The practical applications of naturally occurring thiopeptides are limited by their poor water solubility (<xref rid="B44" ref-type="bibr">Just-Baringo et al., 2014</xref>). Nevertheless, nosiheptide is used as a growth stimulating additive in mixed animal food, while thiostrepton is used to treat skin infections in animals.</p><p>GE2270A, isolated in the early 1990s from actinobacterium <italic>Planobispora rosea</italic> (<xref rid="B80" ref-type="bibr">Selva et al., 1991</xref>), is a representative of the second functional group of thiopeptides. It binds to the elongation factor EF-Tu in a complex with GTP and prevents the formation of the ternary complex with aminoacyl-tRNA (<xref ref-type="fig" rid="F2">Figure 2D</xref>; <xref rid="B37" ref-type="bibr">Heffron and Jurnak, 2000</xref>). A derivative of GE2770A with an altered C-terminus named LFF571, proved to be effective and safe in phase II clinical trials against <italic>Clostridium difficile</italic> infections, a rare case when a RiPP-inspired molecule reached clinical trials (<xref rid="B42" ref-type="bibr">Jarrad et al., 2015</xref>). The GE2270A binding site is located between EF-Tu domains I and III and partially overlaps with the binding site of polyketide antibiotic pulvomycin, an interesting example of two chemically unrelated compounds adopting a similar mode of inhibition of the same molecular target (<xref rid="B71" ref-type="bibr">Parmeggiani et al., 2006</xref>). Other thiopeptides demonstrating similar modes of action, e.g., thiomuracin and GE37468A, are all characterized by the medium size of the macrocycle (29 atoms) and the presence of a conserved Asn or MeAsn residue (<xref ref-type="fig" rid="F2">Figure 2B</xref>, GE2770A, red dashed frame), required for the interaction with EF-Tu (<xref rid="B97" ref-type="bibr">Young et al., 2012</xref>).</p><p>The &#x0201c;core&#x0201d; set of PTMs characterizing most thiopeptides includes the installation of azol(in)e heterocycles, dehydration of amino acids, and macrocyclization <italic>via</italic> the formation of a six-membered azacycle. Azole cycles (<xref ref-type="fig" rid="F2">Figure 2B</xref>, red) are synthesized in a two-step reaction from amino acids with a nucleophilic group in their side chains. First, an YcaO-domain cyclodehydratase together with ThiF-like partner protein (the latter is required for precursor recognition) converts Cys residues into thiazolines and Ser or Thr residues into oxazolines or methyloxazolines, respectively. Flavin mononucleotide (FMN)-dependent dehydrogenase can further oxidize azoline cycles into aromatic azoles. The mechanism of azole installation and diversity of azol(in)e-containing RiPPs were recently reviewed by <xref rid="B11" ref-type="bibr">Burkhart et al. (2017)</xref>.</p><p>The formation of dehydrated amino acids (dehydroalanine from Ser residues and dehydrobutyrine from Thr, <xref ref-type="fig" rid="F2">Figure 2B</xref>, pink) in thiopeptides proceeds <italic>via</italic> a glutamylation-elimination mechanism with tRNA<sup>Glu</sup> functioning as a donor of glutamyl (<xref rid="B40" ref-type="bibr">Hudson et al., 2015</xref>). The enzymes catalyzing this reaction are encoded by two separate genes (so-called &#x0201c;split&#x0201d; LanB), which are also found in BGCs of other, unrelated, RiPPs including class I lanthipeptides. The mechanisms and enzymology of dehydration of amino acids were reviewed by <xref rid="B73" ref-type="bibr">Repka et al. (2017)</xref>. Amino acid dehydration is a prerequisite for the most remarkable modification of thiopeptides&#x02014;formation of the central nitrogen-containing heterocycle (<xref ref-type="fig" rid="F2">Figure 2B</xref>, green). This reaction follows the [4+2] cycloaddition mechanism (aza-Diels-Alder reaction) that is in most cases accompanied by the removal of the leader peptide and leads to the formation of a macrocycle system. The enzymes responsible for catalysis of these reactions in various biosynthetic pathways were reviewed by <xref rid="B43" ref-type="bibr">Jeon et al. (2017)</xref>. The structure of the central azacycle is the basis for thiopeptide classification into series (from <italic>a</italic> to <italic>e</italic>) (<xref rid="B5" ref-type="bibr">Bagley et al., 2005</xref>).</p><p>The genes encoding the enzymes responsible for &#x0201c;core&#x0201d; PTMs mentioned above, together with a precursor peptide gene, constitute the simplest variant of thiopeptide BGC, i.e., the <italic>laz</italic>-cluster of lactazole synthesis (<xref ref-type="fig" rid="F2">Figure 2A</xref>, <xref rid="B35" ref-type="bibr">Hayashi et al., 2014</xref>). Most thiopeptide BGCs are larger and encode the enzymes catalyzing additional modifications (<xref ref-type="fig" rid="F2">Figure 2A</xref>, <italic>nos-</italic> and <italic>tbd</italic>-clusters) as well as transporters and regulatory proteins. The tailoring modifications may include the formation of a side ring system <italic>via</italic> the addition of indole derivates (<xref ref-type="fig" rid="F2">Figure 2B</xref>, blue), modifications of the C-terminus to prevent hydrolysis by carboxypeptidases, glycosylation, hydroxylation, etc. The diversity and mechanisms of thiopeptide PTMs were reviewed in detail by <xref rid="B98" ref-type="bibr">Zheng et al. (2017)</xref>.</p></sec><sec id="S1.SS2"><title>Linear Azol(in)e-Containing Peptides (LAPs)</title><p>The name &#x0201c;linear azol(in)e-containing peptides (LAPs)&#x0201d; refers to the only two characteristics shared by compounds from this diverse subgroup of RiPPs: they (<italic>i</italic>) have azol(in)e cycles installed along the polypeptide backbone and (<italic>ii</italic>) do not undergo macrocyclization (<xref rid="B4" ref-type="bibr">Arnison et al., 2013</xref>). Thus, a minimal LAP BGC comprises only a gene encoding the precursor peptide (gene A) and gene(s) coding for the enzymes involved in the installation of azole cycles: a YcaO-cyclodehydratase (the product of the D gene), which in most cases has a partner protein that is required for leader peptide recognition (either an E1-like protein, the product of the C gene, or a ThiF-like protein encoded by the F gene), and a dehydrogenase (the product of the B gene) which oxidizes azolines to azoles. In some BGCs, genes coding for C and D proteins, are fused and code for a single polypeptide (<xref rid="B11" ref-type="bibr">Burkhart et al., 2017</xref>). The list of additional modifications of LAPs is diverse and includes, among others, N-methylation (plantazolicin, <xref rid="B48" ref-type="bibr">Lee et al., 2013</xref>), the formation of dehydroamino acids and N-terminal acetylation (goadsporin, <xref rid="B69" ref-type="bibr">Ozaki et al., 2016</xref>), N-terminal oxyme formation, and C-terminal O-methylation (azolemycin, <xref rid="B52" ref-type="bibr">Liu et al., 2016</xref>).</p><p>As the set of chemical characteristics required to attribute a compound to LAPs is not particularly restrictive, the group includes compounds without any obvious sequence similarity of peptide precursors. The relationships between the known LAPs (to date there are less than two dozens of well-characterized compounds) resemble a &#x0201c;sea with islands,&#x0201d; where each &#x0201c;island&#x0201d; is formed by a group of the closely related homologs (e.g., streptolysin S with its relatives; <xref rid="B60" ref-type="bibr">Molloy et al., 2011</xref>) without links between the &#x0201c;islands.&#x0201d;</p><p>Klebsazolicin (KLB) is the first characterized translation-targeting LAP (<xref rid="B56" ref-type="bibr">Metelev et al., 2017</xref>). Its BGC was found in the genome of <italic>Klebsiella pneumonia</italic> sub. <italic>ozaenae</italic> and contains a gene for the precursor peptide (<italic>klpA</italic>), genes encoding the enzymes required for azole cycle installation (<italic>klpCBD</italic>), and an exporter pump gene (<italic>klpE</italic>) (<xref ref-type="fig" rid="F3">Figure 3A</xref>). In addition to three thiazoles and one oxazole cycle, KLB has an N-terminal amidine cycle formed by the first two residues of the core part of the precursor peptide (Ser1 and Gln2; <xref ref-type="fig" rid="F3">Figure 3B</xref>), a modification unique among the known LAPs. <italic>In vitro</italic> studies have demonstrated that this cycle is formed after the proteolytic cleavage of the leader peptide and strictly requires the YcaO-domain KlpD cyclodehydratase (<xref rid="B90" ref-type="bibr">Travin et al., 2018</xref>). The amidine cycle is required for KLB to function since the derivatives with a full set of azole cycles, but lacking the amidine cycle, do not inhibit translation. As it is typical for other LAPs, KLB is a narrow spectrum antibiotic: it is active against the genera closely related to <italic>Klebsiella</italic>, including <italic>Yersinia</italic> and <italic>Escherichia</italic>.</p><fig id="F3" position="float"><label>FIGURE 3</label><caption><p>LAPs targeting the ribosome exit tunnel. <bold>(A)</bold> BGCs of klebsazolicin (<italic>klpACBDE</italic>) and phazolicin (<italic>phzEACBD</italic>). The functions of encoded proteins are listed on the right. <bold>(B)</bold> Chemical structures of klebsazolicin (KLB) and phazolicin (PHZ), azole cycles are shown in red, positively charged amino acid side chains of PHZ&#x02014;in blue, the N-terminal amidine cycle of KLB is yellow. <bold>(C)</bold> Mechanism of translation inhibition by KLB (PDB ID 5W4K, <xref rid="B56" ref-type="bibr">Metelev et al., 2017</xref>) and PHZ (PDB ID 6U48, <xref rid="B91" ref-type="bibr">Travin et al., 2019</xref>). Interactions of the two antibiotics with the ribosome are shown: &#x003c0;&#x02013;&#x003c0; stacking is denoted by red arrows and hydrogen bonds with red dashed lines. Nucleobases of 23S rRNA are cyan, ribosomal proteins are magenta, and tRNAs are orange and green. PTC&#x02014;peptidyl-transferase center.</p></caption><graphic xlink:href="fgene-11-00226-g003"/></fig><p>Cocrystallization of KLB with the <italic>Thermus thermophilus</italic> ribosome (which because of ease of crystallization is widely used for structural studies of ribosome-targeting compounds) revealed the molecular details of its mode of action. KLB binds in the upper part of the peptide exit tunnel in a site adjacent to the peptidyl-transferase center (PTC) (<xref ref-type="fig" rid="F3">Figure 3C</xref>). Acting as a cork in the bottle, KLB blocks the passage of the nascent peptide, only allowing the synthesis of di- or tripeptides that remain associated with tRNA and stay bound to the elongating ribosome.</p><p>Phazolicin (PHZ) is another recently discovered ribosome-targeting LAP produced by soil bacterium <italic>Rhizobium</italic> sp. Pop5, a symbiont of wild beans <italic>Phaseolus vulgaris</italic> (<xref rid="B91" ref-type="bibr">Travin et al., 2019</xref>). In terms of the overall composition, PHZ BGC is identical to that of KLB (<xref ref-type="fig" rid="F3">Figure 3A</xref>). PHZ is a 27-amino acid long peptide, every third amino acid of which is converted into an azole cycle. Unlike KLB, no modifications other than Cys and Ser side chain cyclizations are present in PHZ (<xref ref-type="fig" rid="F3">Figure 3B</xref>). PHZ is active against various rhizobia that are closely related to the producing strain. Similarly, to KLB, PHZ targets the ribosome exit tunnel but does this through a different set of interactions, which were revealed by cryo-EM of the <italic>Escherichia coli</italic> ribosome complex with PHZ (<xref ref-type="fig" rid="F3">Figure 3C</xref>). Four azole cycles of PHZ form a &#x003c0;&#x02013;&#x003c0; stacking system, which stabilizes 3D globular structure of the peptide, while the three azoles are involved in stacking with nucleobases of the 23S rRNA. Unlike KLB, PHZ has three positively charged residues involved in the interactions with phosphates and other polar groups of 23S rRNA. PHZ also interacts with the loop regions of two ribosomal proteins (uL4 and uL22). Amino acid sequences of these loops confer the species-specific mode of translation inhibition by PHZ, which, unlike KLB, does not bind to <italic>T. thermophilus</italic> ribosome.</p></sec><sec id="S1.SS3"><title>Bottromycins</title><p>Bottromycins are extensively modified RiPPs that exhibit potent antimicrobial activity against the drug-resistant human pathogens including vancomycin-resistant <italic>Enterococcus</italic> (VRE) and methicillin-resistant <italic>Staphylococcus aureus</italic> (MRSA) (<xref rid="B84" ref-type="bibr">Shimamura et al., 2009</xref>). In early works, bottromycin A2 was demonstrated to inhibit protein synthesis both <italic>in vitro</italic> and <italic>in vivo</italic> (<xref rid="B88" ref-type="bibr">Tanaka et al., 1966</xref>). Further studies showed that the action of bottromycin does not interfere with the peptide bond formation and translocation steps. Bottromycins are believed to bind in the A-site of the ribosome (<xref rid="B66" ref-type="bibr">Otaka and Kaji, 1976</xref>, <xref rid="B67" ref-type="bibr">1981</xref>, <xref rid="B68" ref-type="bibr">1983</xref>) and block the interaction of aminoacyl-tRNAs with the ribosome, almost an unexploited target among the currently used antibiotics. However, further structural studies of bottromycin mechanism of action are needed to establish the details of this interaction at a molecular level, as previous studies used indirect approaches sometimes leading to contradictory conclusions.</p><p>Although the first representative of the bottromycin family of RiPPs was isolated from <italic>Streptomyces bottropensis</italic> in 1957 (<xref rid="B94" ref-type="bibr">Waisvisz et al., 1957</xref>), more than 50 years passed until the structure of the compound was finally confirmed by total chemical synthesis (<xref rid="B84" ref-type="bibr">Shimamura et al., 2009</xref>). Bottromycins are eight-amino acid long extensively modified peptides originating from the N-terminal part of a precursor peptide (thus bottromycin precursor has a &#x0201c;follower&#x0201d; peptide to which modification machinery binds, rather than N-terminal &#x0201c;leader&#x0201d; common among other RiPPs). The biosynthesis of bottromycin includes many steps and was intensively studied using the untargeted methabolomics approach (<xref rid="B17" ref-type="bibr">Crone et al., 2016</xref>) and <italic>in vitro</italic> reconstitution of separate modification reactions. The PTMs characteristic to bottromycins include the formation of the N-terminal macroamidine cycle (<xref ref-type="fig" rid="F4">Figure 4A</xref>, green) and C-terminal thiazole (<xref ref-type="fig" rid="F4">Figure 4A</xref>, red) catalyzed by two divergent YcaO-domain enzymes acting without any partner proteins (so-called &#x0201c;standalone YcaOs&#x0201d;) (<xref rid="B25" ref-type="bibr">Franz et al., 2017</xref>; <xref rid="B79" ref-type="bibr">Schwalen et al., 2017</xref>). In addition to these cyclizations, C<sub>&#x003b2;</sub>-methylations of Pro, Phe, and Val residues, as well as O-methylation of aspartate take place (<xref ref-type="fig" rid="F4">Figure 4A</xref>, gray background; <xref rid="B41" ref-type="bibr">Huo et al., 2012</xref>). Different methylation profiles lead to multiple forms of bottromycins produced by the same strain (<xref rid="B24" ref-type="bibr">Eyles et al., 2018</xref>). In addition to the genes encoding YcaO heterocyclases and methyltransferases, bottromycin BGC includes genes encoding an enzyme, which removes the N-terminal methionine residue (<xref rid="B54" ref-type="bibr">Mann et al., 2016</xref>), an amidohydrolase required for the follower peptide removal (<xref rid="B85" ref-type="bibr">Sikandar et al., 2019</xref>), a cytochrome performing oxidative decarboxylation of the C-terminal azoline into azole, and a transporter (<xref ref-type="fig" rid="F4">Figure 4A</xref>).</p><fig id="F4" position="float"><label>FIGURE 4</label><caption><p>Translation-targeting RiPPs without structural information on target binding <bold>(A)</bold> BGC and chemical structure of bottromycin A2 from <italic>Streptomyces bottropensis</italic>. C-terminal thiazole is shown in red, macroamidine bond is green, and C<sub>&#x003b2;</sub>-methyl groups are shown on the gray background. <bold>(B)</bold> BGC of microcin C, chemical structures of unprocessed microcin C and of processed form, an analog of aspartyl adenylate. The non-hydrolyzable N&#x02013;P bond is shown in red.</p></caption><graphic xlink:href="fgene-11-00226-g004"/></fig></sec><sec id="S1.SS4"><title>Microcin C and Related Compounds</title><p>Microcin C (McC) is a peptide-nucleotide antibiotic produced by <italic>E. coli</italic> strains bearing a plasmid with a six-gene <italic>mcc</italic> gene cluster (<xref ref-type="fig" rid="F4">Figure 4B</xref>), which encodes a seven amino acid-long precursor peptide (MccA, MRTGNAN), enzymes responsible for its PTM (MccB, MccD, and MccE), an exporter pump (MccC), and a peptidase providing autoimmunity (MccF). The product of the <italic>mccA</italic> gene is adenylated by MccB, which leads to the formation of a non-hydrolyzable N-P bond between C-terminal asparagine and phosphate (<xref rid="B75" ref-type="bibr">Roush et al., 2008</xref>). MccD and MccE are required for additional decoration of the molecule with aminopropyl group attached to the phosphate (<xref rid="B47" ref-type="bibr">Kulikovsky et al., 2014</xref>). Recent studies increased the number of McC-related compounds: RiPPs of this family undergoing cytidylation instead of adenylation were discovered, and carboxymethylation of the cytidine was shown to be an additional tailoring step required for an optimal bioactivity (<xref rid="B81" ref-type="bibr">Serebryakova et al., 2016</xref>; <xref rid="B92" ref-type="bibr">Tsibulskaya et al., 2017</xref>).</p><p>Microcin C is a Trojan-horse antibiotic imported into sensitive cells <italic>via</italic> the inner membrane transporter YejABEF, which recognizes the peptide part of McC (<xref rid="B64" ref-type="bibr">Novikova et al., 2007</xref>). The McC molecule itself is not toxic for the cell; the peptide part has to be deformylated and subsequently degraded by non-specific cellular oligopeptidases (<xref rid="B46" ref-type="bibr">Kazakov et al., 2008</xref>) to release a nonhydrolyzable analog of aspartyl adenylate, a potent inhibitor of aspartyl-tRNA synthetase (<xref ref-type="fig" rid="F4">Figure 4B</xref>, gray background) (<xref rid="B58" ref-type="bibr">Metlitskaya et al., 2006</xref>). This leads to the accumulation of uncharged tRNA<sup>Asp</sup>, inhibition of protein synthesis, and the cessation of cell growth. Thus, McC is another example of a RiPP (together with GE2270A discussed earlier), which does not directly interact with the ribosome but blocks translation by inhibiting the supply of substrates required for protein synthesis. Although McC has been studied for more than 30 years and structures of multiple enzymes involved in its biosynthesis and immunity have been determined (<xref rid="B2" ref-type="bibr">Agarwal et al., 2011</xref>, <xref rid="B3" ref-type="bibr">2012</xref>; <xref rid="B20" ref-type="bibr">Dong et al., 2019</xref>), we still lack structural information about the details of McC interaction with aspartyl-tRNA synthetase.</p></sec></sec><sec id="S2"><title>Genome Mining for Novel Translation Inhibiting Ripps</title><p>In light of the data discussed above, it is evident that many translation-targeting RiPPs contain azol(in)e cycles. At least in several cases where the mode of interaction with a ribosome is known, these cycles take part in stacking interactions with rRNA nucleobases thus mediating binding of the inhibitor to the target. We decided to perform a search for novel groups of azol(in)e-containing RiPPs in the genomes present in publicly available databases with a goal of identifying the putative translation inhibitors as well as other bioactive molecules. Due to their essential role in azol(in)e-containing RiPP biosynthesis, the genes encoding the YcaO-domain-containing enzymes were chosen as a starting point for our search.</p><p>In less than 10 years YcaO-domain containing enzymes went from being DUFs (domains of unknown function) to one of the most studied groups of RiPP modification proteins (<xref rid="B11" ref-type="bibr">Burkhart et al., 2017</xref>). It was demonstrated that YcaO enzymes play the key role in the catalysis of three distinct reactions of PTM of proteins and peptides including the installation of azoline cycles (<xref rid="B21" ref-type="bibr">Dunbar et al., 2012</xref>), amidines (<xref rid="B11" ref-type="bibr">Burkhart et al., 2017</xref>; <xref rid="B25" ref-type="bibr">Franz et al., 2017</xref>; <xref rid="B90" ref-type="bibr">Travin et al., 2018</xref>), and thioamides (<xref rid="B53" ref-type="bibr">Mahanta et al., 2018</xref>; <xref rid="B78" ref-type="bibr">Schwalen et al., 2018</xref>). A common mechanism involving the nucleophilic attack on the amide bond containing substrate with a subsequent ATP-dependent phosphorylation of the intermediate followed by phosphate elimination underlies all these activities. Three groups of proteins are regarded as YcaO partners, allowing for the interaction of the enzyme with its substrate (the recognition of the leader peptide in case of RiPP biosynthesis). These are E1-like proteins and ThiF-like proteins, fused or clustered together with azoline-forming YcaOs (<xref rid="B11" ref-type="bibr">Burkhart et al., 2017</xref>), and TfuA-like proteins considered to be a hallmark of the BGCs of thioamidated compounds (<xref rid="B76" ref-type="bibr">Santos-Aberturas et al., 2019</xref>).</p><p>To identify new BGCs of azol(in)e-containing compounds, we started with a sensitive search for sequences of YcaO domain-containing enzymes present in genomes from the RefSeq database (<xref rid="B65" ref-type="bibr">O&#x02019;Leary et al., 2016</xref>). In brief, the subsequent steps included filtering, clusterization, and annotation of genomic regions surrounding the recovered <italic>ycaO</italic> genes (<xref ref-type="fig" rid="F5">Figure 5</xref>). To visualize the obtained diversity and to identify families of BGCs, we constructed a sequence similarity network of all YcaO-containing BGCs, which was then analyzed manually (for detailed description of procedures, see section &#x0201c;Methods&#x0201d;). A curated set of characterized YcaO-containing BGCs including those present in the MIBiG database (<xref rid="B45" ref-type="bibr">Kautsar et al., 2019</xref>) or described elsewhere in the literature (including previous bioinformatic predictions) was used as a reference (<xref ref-type="supplementary-material" rid="TS1">Supplementary Table S1</xref>). In the current study, we focused only on clusters containing E1-like or a ThiF-like partner proteins and did not consider TfuA-containing BGCs or BGCs with standalone YcaOs. We also did not consider BGCs of thiopeptides and closely related RiPPs (defined as clusters containing <italic>lanB</italic>-like genes) as they were recently searched with various tools (<xref rid="B49" ref-type="bibr">Li et al., 2012</xref>; <xref rid="B78" ref-type="bibr">Schwalen et al., 2018</xref>). The genomic landscape of all azol(in)e-containing peptides was studied by <xref rid="B16" ref-type="bibr">Cox et al. (2015)</xref>, however, since the time of this publication new azol(in)e-containing RiPPs with characterized modes of action (including ribosome-targeting KLB and PHZ) have been discovered, and many more sequenced genomes have been deposited in publicly available databases. Moreover, several improved methods and software have become available.</p><fig id="F5" position="float"><label>FIGURE 5</label><caption><p>A workflow for identification of YcaO-containing RiPP BGCs.</p></caption><graphic xlink:href="fgene-11-00226-g005"/></fig><p><xref ref-type="fig" rid="F6">Figure 6</xref> represents a similarity network of YcaO-containing BGCs encoding E1-like (<xref ref-type="fig" rid="F6">Figure 6A</xref>) or ThiF-like (<xref ref-type="fig" rid="F6">Figure 6B</xref>) YcaO partner proteins (see <xref ref-type="supplementary-material" rid="TS2">Supplementary Table S2</xref> for the list of all BGCs). BGCs of the already characterized compounds from the curated dataset are shown as blue circles. In the network with E1-like partners, these include BGCs of bioactive antibacterials McB, KLB, and PHZ as well as a number of streptolysin S-like RiPPs (clostridilysin S; listeriolysin S; <xref rid="B15" ref-type="bibr">Cotter et al., 2008</xref>; <xref rid="B30" ref-type="bibr">Gonzalez et al., 2010</xref>) and hakacin, whose biosynthesis was studied <italic>in vitro</italic>, but the structure of the naturally produced compound remains unknown (<xref rid="B55" ref-type="bibr">Melby et al., 2012</xref>; <xref rid="B22" ref-type="bibr">Dunbar and Mitchell, 2013</xref>). In the network of ThiF-like protein containing BGCs we observed a large group of heterocycloanthracin (HCA) BGCs, which include the already characterized sonorensin (<xref rid="B13" ref-type="bibr">Chopra et al., 2014</xref>) and HCA from <italic>Bacillus thuringiensis</italic> Al Hakam (<xref rid="B23" ref-type="bibr">Dunbar et al., 2015</xref>).</p><fig id="F6" position="float"><label>FIGURE 6</label><caption><p>A similarity network of YcaO-containing BGCs with E1-like <bold>(A)</bold> and ThiF-like <bold>(B)</bold> partner proteins. Nodes representing BGCs of already characterized compounds are shown in blue, nodes representing BGCs analyzed in <xref rid="B16" ref-type="bibr">Cox et al. (2015)</xref> are red. BGCs containing an <italic>mcbG</italic>-homolog are denoted with red &#x0201c;G.&#x0201d; Groups of clusters discussed in the text are shown in orange ellipses. Light blue color of nodes in group 2 shows BGCs from genus <italic>Pseudomonas.</italic> SLS&#x02014;strepolysin S, LLS&#x02014;listeriolysin S, CLS&#x02014;clostridiolysin S, HCA&#x02014;heterocycloanthracin.</p></caption><graphic xlink:href="fgene-11-00226-g006"/></fig><p>Below, we discuss three groups of BGCs, which attracted our attention during the analysis of the networks and putative peptides encoded by these BGCs as predicted by RiPPER (<xref rid="B76" ref-type="bibr">Santos-Aberturas et al., 2019</xref>) in <xref ref-type="fig" rid="F6">Figure 6</xref>. We consider it likely that the first group of these BGCs encodes new translation targeting RiPPs; the second may also do so, while the third was so interesting in terms of RiPP encoding clusters&#x02019; evolution, that we could not help but discuss it in this article.</p><sec id="S2.SS1"><title>Lactazolicins</title><p>The first group of BGCs contains clusters from the representatives of the genus <italic>Lactobacillus</italic>, which form a connected component with PHZ BGC (<xref ref-type="fig" rid="F6">Figure 6</xref>, Group 1). Analysis of these BGCs and their homologs from genera <italic>Enterococcus</italic> and <italic>Streptococcus</italic> found with an additional BLAST search revealed that all these BGCs share the same set of genes, which, in addition to modification machinery and export pump homologs of those in PHZ BGC (<xref ref-type="fig" rid="F7">Figure 7A</xref>, genes E, C, B, and D<sub>2</sub>), includes three auxiliary genes (<xref ref-type="fig" rid="F7">Figure 7A</xref>, genes X<sub>1</sub>, D<sub>1</sub>, and X<sub>2</sub>). The product of gene D<sub>1</sub> is the second YcaO protein. It is distinct from the product of the D<sub>2</sub> gene and lacks the C-terminal PxP-motif, found in azoline-forming YcaOs and involved in catalysis (<xref rid="B28" ref-type="bibr">Ghilarov et al., 2019</xref>). According to the results of HHPred (<xref rid="B86" ref-type="bibr">S&#x000f6;ding et al., 2005</xref>), the product of gene X<sub>2</sub> is distantly related to ThiF/MccB/PaaA proteins and contains a RiPP recognition element (RRE) &#x02014; a domain found in different RiPP modification enzymes binding leader peptides (<xref rid="B10" ref-type="bibr">Burkhart et al., 2015</xref>). The presence of the second YcaO and of the X<sub>2</sub> gene product, which could function either as a partner protein or an independent adenylating enzyme (<xref rid="B29" ref-type="bibr">Ghodge et al., 2016</xref>; <xref rid="B20" ref-type="bibr">Dong et al., 2019</xref>), makes additional modifications of the precursor peptide highly probable. We were unable to detect any homologs of the X<sub>1</sub> gene product among the known proteins.</p><fig id="F7" position="float"><label>FIGURE 7</label><caption><p><bold>(A)</bold> Common BGC composition conserved among lactazolicin BGCs, proposed functions of the encoded proteins are listed on the right. RiPP recognition elements (RREs) in C and X<sub>2</sub> genes are depicted. Alignment of precursor peptides of lactazolicins, predicted leader and core parts are shown. Cysteines in the core part are shown on red background, positively charged amino acids of the predicted core are blue, and negatively charged residues are green. <bold>(B)</bold> The composition of McB-like BGC from pseudomonads. <italic>mcbG</italic> homolog is shown in square brackets as it is not present in the majority of clusters from pseudomonads, the genes are colored according to the color scheme in <bold>(A)</bold>. Alignment of precursor peptides predicted with RiPPER, those encoded in PRP gene-containing BGCs are in magenta frame. Potentially cyclized residues are shown with red background, predicted core and leader parts are shown.</p></caption><graphic xlink:href="fgene-11-00226-g007"/></fig><p>Following the conventional practice of giving names to the proposed new groups of compounds (<xref rid="B16" ref-type="bibr">Cox et al., 2015</xref>) and in accordance with the nomenclature recommended for LAPs (<xref rid="B4" ref-type="bibr">Arnison et al., 2013</xref>), we named this group of putative translation inhibitors <italic>lactazolicins</italic>. All lactazolicin clusters encode 83-106 amino acid-long putative precursor peptides with 8&#x02013;12 repeats of the [Cxxx] motif in the N-terminal part of the predicted core segment (<xref ref-type="fig" rid="F7">Figure 7A</xref>). HCAs represent an already known group of RiPPs, which have a similar pattern of repeated cysteine residues in the core part (<xref rid="B33" ref-type="bibr">Haft, 2009</xref>). However, HCA precursors (also found in our search, <xref ref-type="fig" rid="F6">Figure 6B</xref>, the largest group of BGCs) have the [Cxx] motif repeated rather than [Cxxx], and the overall composition of HCA BGCs also differs significantly from that of lactazolicin BGCs. Unlike HCAs, where the [Cxx]-repeat containing part of the precursor is rich in glycines, the N-terminal [Cxxx] repeat-containing part of lactazolicin precursors is enriched in positively charged amino acids (Arg, Lys). In the cases of PHZ and proline-rich peptides (which do not belong to RiPPs but also target the ribosome exit tunnel) (<xref rid="B26" ref-type="bibr">Gagnon et al., 2016</xref>), the side chains of positively charged amino acids take part in the interaction with phosphate groups of rRNA. We thus hypothesize that lactazolicins may also affect translation.</p></sec><sec id="S2.SS2"><title>Microcin B17-Like BGCs From Pseudomonads</title><p>Microcin B17 is a DNA-gyrase-targeting LAP produced by some strains of <italic>E. coli</italic>. The McB BGC contains a set of enzymes similar to those encoded by the KLB and PHZ BGCs and an additional gene <italic>mcbG</italic>, which encodes a pentapeptide repeat protein (PRP) (<xref rid="B51" ref-type="bibr">Li et al., 1996</xref>; <xref rid="B36" ref-type="bibr">Heddle et al., 2001</xref>). McbG is likely a DNA mimic that decreases the formation of toxic gyrase-DNA complexes trapped by McB, thus protecting the gyrase in the McB-producing cell (<xref rid="B38" ref-type="bibr">Hegde et al., 2005</xref>; <xref rid="B93" ref-type="bibr">Vetting et al., 2011</xref>). Clusters similar to that of McB were described in the genomes of several pathovars of <italic>Pseudomonas syringae</italic> and their products also target gyrase (<xref rid="B57" ref-type="bibr">Metelev et al., 2013</xref>).</p><p>A relatively large network of clusters retrieved by our search (<xref ref-type="fig" rid="F6">Figure 6A</xref>, Group 2) contains no previously characterized representatives except for an <italic>mcb-</italic>operon homolog from <italic>P. syringae</italic> (blue circle). However, several of these clusters (marked with red letter G) contain a gene coding for a PRP protein. The overall sequence similarity and the distribution of potentially cyclizable residues in precursor peptides from clusters with and without the PRP gene differ (<xref ref-type="fig" rid="F7">Figure 7B</xref>). Thus, it is highly probable that <italic>mcb</italic>-like clusters without a PRP gene encode a RiPP with a target distinct from DNA gyrase. While we cannot establish whether these are translation-targeting RiPPs, compounds with the same set of proteins in their BGC (KLB and PHZ) do affect translation.</p></sec><sec id="S2.SS3"><title>Flavazolicins</title><p>The last group of putative new LAP BGCs was identified during the analysis of precursor peptides predicted with RiPPER (<xref rid="B76" ref-type="bibr">Santos-Aberturas et al., 2019</xref>). The precursor peptide identified in the genome of flavobacterium <italic>Algibacter aquaticus</italic> SK-16 (a singlet and therefore not shown in <xref ref-type="fig" rid="F6">Figure 6A</xref>; <xref ref-type="fig" rid="F8">Figure 8A</xref>) appears to have resulted from a duplication of a standard leader-core ancestral precursor gene (<xref ref-type="fig" rid="F8">Figure 8B</xref>). As a result, in a single ORF, there are two putative core sequences rich in Ser and Cys residues separated by an &#x0201c;internal&#x0201d; leader (another leader is N-terminally located) (<xref ref-type="fig" rid="F8">Figure 8C</xref>). A similar cassette-like arrangement of core peptides has been described for several different groups of RiPPs including cyanobactins (<xref rid="B32" ref-type="bibr">Gu et al., 2018</xref>), thiovarsolines (<xref rid="B76" ref-type="bibr">Santos-Aberturas et al., 2019</xref>), orbitides (<xref rid="B83" ref-type="bibr">Shim et al., 2015</xref>), and dikaritins (<xref rid="B19" ref-type="bibr">Ding et al., 2016</xref>); but in all these cases, precursors are composed of a single leader, followed by several core peptides, interspersed by signal sequences required for the cleavage of each core at C- and N-termini by dedicated peptidases (<xref ref-type="fig" rid="F8">Figure 8B</xref> shows, as an example, the sequence of TruE1 &#x02014; the precursor of patellins 2 and 3, representatives of cyanobactins).</p><fig id="F8" position="float"><label>FIGURE 8</label><caption><p>Flavazolicines. <bold>(A)</bold> Comparison of biosynthetic gene clusters encoding a putative new group of LAPs found in <italic>Flavobacteria</italic> and <italic>Gammaproteobacteria</italic> genomes. Predicted functions of the Encoded proteins are listed below. <bold>(B)</bold> Comparison of precursor peptides of flavazolicins. Conserved core sequences containing cyclizable residues are shown with red background. The precursor peptide sequence of cyanobactins patellins 2 and 3 (<italic>truE1</italic> gene product) is shown for comparison on the gray background. Functional parts of the peptide including leader (yellow), two cores (red), and recognition sequences of peptidases (RS1 and RS2) are shown (<xref rid="B32" ref-type="bibr">Gu et al., 2018</xref>). <bold>(C)</bold> Sequences of cassette-containing precursor peptides of flavazolicins showing the conserved positions in two leader sequences. Conserved positions are shown with green dashed lines, synonymous substitutions with yellow dashed lines. <bold>(D)</bold> A possible scenario in the evolution of cassette-containing peptides. See main text for the explanations.</p></caption><graphic xlink:href="fgene-11-00226-g008"/></fig><p>A BLAST search for similar BGCs resulted in identifying six additional BGCs, that share the same set of modification enzymes (<xref ref-type="fig" rid="F8">Figure 8A</xref>). The first three originate from the genomes of <italic>Flavobacteriaceae</italic> closely related to <italic>Algibacter</italic>, while three others were found in the genomes of <italic>Gammaproteobacteria</italic>. Interestingly, only two of these clusters contained a fused precursor peptide gene, while the rest had a set of one to three separate ORFs encoding non-fused precursor peptides (<xref ref-type="fig" rid="F8">Figure 8B</xref>). These different genome arrangements from the closely related species provide a glimpse on how the genes of cassette-containing peptides may originate from an independent single short ORF through gene duplication [<xref ref-type="fig" rid="F8">Figure 8D</xref>(1)], fusion [<xref ref-type="fig" rid="F8">Figure 8D</xref>(2)], and a subsequent reduction of the role of the internal leader to that of a recognition sequence of proteases [<xref ref-type="fig" rid="F8">Figure 8D</xref>(4)]. Further multiplication of cassette-containing precursor genes may lead to arrangements found in several cyanobactin clusters [<xref ref-type="fig" rid="F8">Figure 8D</xref>(5); <xref rid="B32" ref-type="bibr">Gu et al., 2018</xref>].</p><p>Strikingly, only the BGCs with fused precursors contain an additional gene, which is a predicted protease (<xref ref-type="fig" rid="F8">Figure 8A</xref>, orange). This enzyme may be involved in the processing required to produce individual modified core parts. The acquisition of an additional protease gene may be the step that follows the fusion of two independent ORFs in the course of cassette-containing BGC evolution [<xref ref-type="fig" rid="F8">Figure 8D</xref>(3)]. We named the products of this family of BGCs <italic>flavazolicins</italic>. Characterizing the products encoded in these BGCs and establishing the details of their biosynthesis and function appears to be an exciting direction of future work.</p></sec></sec><sec id="S3"><title>Concluding Remarks</title><p>Although the number of the known subclasses and unique representatives of RiPPs increases each year, a remarkable proportion of publications devoted to novel compounds provides information only about the structure and sometimes evaluates the bioactivity of a modified peptide. Researchers focusing on RiPP clusters as a source of unprecedented enzymatic activities rarely proceed toward establishing the mode of action of the target compound and are even less likely to establish its physiological or ecological role. Addressing these questions is a challenging task, which partially explains the lack of detailed information about the precise mechanisms of action for many groups of RiPPs, including some that are known and have been studied for decades (e.g., bottromycin, McB). We hope that the upcoming years will provide more structural insights not only on the enzymology of RiPP modification widely studied now, but also on the principles the already known and novel compounds act by.</p><p>In many cases, the analysis of genomic information was a starting point for further successful discoveries of a novel RiPP, facilitating the prediction of the BGC product based on the sequences of precursor peptides and modification enzymes. Through genome mining, future studies will not only result in the discovery of new compounds but will also allow systemization of our knowledge about RiPP genomic landscape and a better understanding of RiPP clusters&#x02019; evolutionary relations.</p></sec><sec id="S4"><title>Methods</title><sec id="S4.SS1"><title>Search for YcaO Containing BGCs, Filtration, and Annotation</title><p>146,381 bacterial genomes were downloaded from RefSeq (<xref rid="B65" ref-type="bibr">O&#x02019;Leary et al., 2016</xref>) database on 27 March 2019. To obtain all YcaO domain-containing proteins we searched the database with profile HMMs (TIGR03549, TIGR03604, and PF02624) from public databases using hmmer package<sup><xref ref-type="fn" rid="footnote1">1</xref></sup>. We clustered resulting hits with mmseqs2 (<xref rid="B59" ref-type="bibr">Mirdita et al., 2019</xref>) (90% identity; 90% coverage) to remove duplicates and redundant highly similar sequences from organisms, which genome sequences are overrepresented in the database.</p><p>The genomic regions of 12.5 kbp to each side of the identified unique YcaO protein-coding genes were annotated with RODEO (<xref rid="B89" ref-type="bibr">Tietz et al., 2017</xref>) using Pfam 32.0 and TIGRFAMs 15.0 databases. For further analysis, we selected genomic regions according to several rules. First, we collected regions that encode proteins containing E1-like (PF00881, TIGR03603, TIGR04424) or ThiF-like (PF00899, TIGR02354, TIGR02356, TIGR03693, TIGR03736, TIGR03882) domains. Initial search was very sensitive and false positive results were obtained. Thus, we removed predicted YcaO proteins that were not annotated with TIGR03549, TIGR03604, or PF02624 domains in the RODEO output. In order to exclude thiopeptides, studied comprehensively in several other works, we removed genomic regions containing genes of lantipeptide dehydratase (PF14028, PF04738, TIGR03897, PF05147). Putative precursor peptides were predicted with RiPPER (<xref rid="B76" ref-type="bibr">Santos-Aberturas et al., 2019</xref>). For each BGC, the best predicted precursor peptide was selected as the one bearing the highest number of cyclizable residues (Ser, Thr, Cys residues) within the C-terminal half.</p><p>Using a custom script (available on <ext-link ext-link-type="uri" xlink:href="http://github.com/bikdm12/RODEO2antiSMASH">http://github.com/bikdm12/RODEO2antiSMASH</ext-link>) we converted RODEO output to genbank files imitating antiSMASH (<xref rid="B7" ref-type="bibr">Blin et al., 2019</xref>) output. The script adds a feature &#x0201c;cluster&#x0201d; with information about the class of the product. The coordinates of this feature are boundaries of the group of genes located on the same strand not farther than 100 bps from each other and containing YcaO protein. Also, genes that may be related to azol(in)e-containing RiPP biosynthesis (for the list of domains see <xref ref-type="supplementary-material" rid="TS3">Supplementary Table S3</xref>) were marked as biosynthetic. These files were then used to build a sequence similarity network with BiG-SCAPE (<xref rid="B62" ref-type="bibr">Navarro-Mu&#x000f1;oz et al., 2020</xref>) subsequently visualized with Cytoscape (<xref rid="B82" ref-type="bibr">Shannon et al., 2003</xref>).</p></sec></sec><sec id="S5"><title>Author Contributions</title><p>DT and DB performed the bioinformatic search and interpreted its results. DT prepared the figures. All authors wrote the manuscript.</p></sec><sec id="conf1"><title>Conflict of Interest</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></body><back><fn-group><fn fn-type="financial-disclosure"><p><bold>Funding.</bold> This work was supported by RSF grant number 19-14-00266 to Svetlana Dubiley.</p></fn></fn-group><ack><p>We thank Dr. Dmitry Ghilarov, Ms. Elena Smertina, and Dr. Svetlana Dubiley for critical reading of the manuscript and valuable suggestions.</p></ack><fn-group><fn id="footnote1"><label>1</label><p><ext-link ext-link-type="uri" xlink:href="http://hmmer.org">hmmer.org</ext-link></p></fn></fn-group><sec id="S8" sec-type="supplementary material"><title>Supplementary Material</title><p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fgene.2020.00226/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fgene.2020.00226/full#supplementary-material</ext-link></p><supplementary-material content-type="local-data" id="TS1"><label>TABLE S1</label><caption><p>Manually curated set of previously characterized YcaO-containing BGCs (including bioinformatically predicted, but not validated experimentally).</p></caption><media xlink:href="Table_1.XLSX"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="TS2"><label>TABLE S2</label><caption><p>List of YcaO-containing BGCs with E1-like or ThiF-like YcaO partner proteins identified in this study (exluding clusters encoding lantipeptide dehydratases).</p></caption><media xlink:href="Table_2.XLSX"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="TS3"><label>TABLE S3</label><caption><p>List of Pfam and TIGRFAMs profile HMMs used to mark biosynthetic genes.</p></caption><media xlink:href="Table_3.XLSX"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec><ref-list><title>References</title><ref id="B1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ackerley</surname><given-names>D. F.</given-names></name></person-group> (<year>2016</year>). <article-title>Cracking the nonribosomal code.</article-title>
<source><italic>Cell Chem. Biol.</italic></source>
<volume>23</volume>
<fpage>535</fpage>&#x02013;<lpage>537</lpage>. <pub-id pub-id-type="doi">10.1016/j.chembiol.2016.05.001</pub-id>
<?supplied-pmid 27203372?><pub-id pub-id-type="pmid">27203372</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agarwal</surname><given-names>V.</given-names></name><name><surname>Metlitskaya</surname><given-names>A.</given-names></name><name><surname>Severinov</surname><given-names>K.</given-names></name><name><surname>Nair</surname><given-names>S. K.</given-names></name></person-group> (<year>2011</year>). <article-title>Structural basis for microcin C7 inactivation by the MccE acetyltransferase.</article-title>
<source><italic>J. Biol. Chem.</italic></source>
<volume>286</volume>
<fpage>21295</fpage>&#x02013;<lpage>21303</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M111.226282</pub-id>
<?supplied-pmid 21507941?><pub-id pub-id-type="pmid">21507941</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agarwal</surname><given-names>V.</given-names></name><name><surname>Tikhonov</surname><given-names>A.</given-names></name><name><surname>Metlitskaya</surname><given-names>A.</given-names></name><name><surname>Severinov</surname><given-names>K.</given-names></name><name><surname>Nair</surname><given-names>S. K.</given-names></name></person-group> (<year>2012</year>). <article-title>Structure and function of a serine carboxypeptidase adapted for degradation of the protein synthesis antibiotic microcin C7.</article-title>
<source><italic>Proc. Natl. Acad. Sci. U.S.A.</italic></source>
<volume>109</volume>
<fpage>4425</fpage>&#x02013;<lpage>4430</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1114224109</pub-id>
<?supplied-pmid 22388748?><pub-id pub-id-type="pmid">22388748</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arnison</surname><given-names>P. G.</given-names></name><name><surname>Bibb</surname><given-names>M. J.</given-names></name><name><surname>Bierbaum</surname><given-names>G.</given-names></name><name><surname>Bowers</surname><given-names>A. A.</given-names></name><name><surname>Bugni</surname><given-names>T. S.</given-names></name><name><surname>Bulaj</surname><given-names>G.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature.</article-title>
<source><italic>Nat. Prod. Rep.</italic></source>
<volume>30</volume>
<fpage>108</fpage>&#x02013;<lpage>160</lpage>. <pub-id pub-id-type="doi">10.1039/c2np20085f</pub-id>
<?supplied-pmid 23165928?><pub-id pub-id-type="pmid">23165928</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bagley</surname><given-names>M. C.</given-names></name><name><surname>Dale</surname><given-names>J. W.</given-names></name><name><surname>Merritt</surname><given-names>E. A.</given-names></name><name><surname>Xiong</surname><given-names>X.</given-names></name></person-group> (<year>2005</year>). <article-title>Thiopeptide antibiotics.</article-title>
<source><italic>Chem. Rev.</italic></source>
<volume>105</volume>
<fpage>685</fpage>&#x02013;<lpage>714</lpage>. <pub-id pub-id-type="doi">10.1021/cr0300441</pub-id>
<?supplied-pmid 15700961?><pub-id pub-id-type="pmid">15700961</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baltz</surname><given-names>R. H.</given-names></name></person-group> (<year>2019</year>). <article-title>Natural product drug discovery in the genomic era: realities, conjectures, misconceptions, and opportunities.</article-title>
<source><italic>J. Ind. Microbiol. Biotechnol.</italic></source>
<volume>46</volume>
<fpage>281</fpage>&#x02013;<lpage>299</lpage>. <pub-id pub-id-type="doi">10.1007/s10295-018-2115-4</pub-id>
<?supplied-pmid 30484124?><pub-id pub-id-type="pmid">30484124</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blin</surname><given-names>K.</given-names></name><name><surname>Shaw</surname><given-names>S.</given-names></name><name><surname>Steinke</surname><given-names>K.</given-names></name><name><surname>Villebro</surname><given-names>R.</given-names></name><name><surname>Ziemert</surname><given-names>N.</given-names></name><name><surname>Lee</surname><given-names>S. Y.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>antiSMASH 5.0: updates to the secondary metabolite genome mining pipeline.</article-title>
<source><italic>Nucleic Acids Res.</italic></source>
<volume>47</volume>
<fpage>W81</fpage>&#x02013;<lpage>W87</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkz310</pub-id>
<?supplied-pmid 31032519?><pub-id pub-id-type="pmid">31032519</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brandi</surname><given-names>L.</given-names></name><name><surname>Marzi</surname><given-names>S.</given-names></name><name><surname>Fabbretti</surname><given-names>A.</given-names></name><name><surname>Fleischer</surname><given-names>C.</given-names></name><name><surname>Hill</surname><given-names>W. E.</given-names></name><name><surname>Gualerzi</surname><given-names>C. O.</given-names></name><etal/></person-group> (<year>2004</year>). <article-title>The translation initiation functions of IF2: targets for thiostrepton inhibition.</article-title>
<source><italic>J. Mol. Biol.</italic></source>
<volume>335</volume>
<fpage>881</fpage>&#x02013;<lpage>894</lpage>. <pub-id pub-id-type="doi">10.1016/j.jmb.2003.10.067</pub-id>
<?supplied-pmid 14698286?><pub-id pub-id-type="pmid">14698286</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>E. D.</given-names></name><name><surname>Wright</surname><given-names>G. D.</given-names></name></person-group> (<year>2016</year>). <article-title>Antibacterial drug discovery in the resistance era.</article-title>
<source><italic>Nature</italic></source>
<volume>529</volume>
<fpage>336</fpage>&#x02013;<lpage>343</lpage>. <pub-id pub-id-type="doi">10.1038/nature17042</pub-id>
<?supplied-pmid 26791724?><pub-id pub-id-type="pmid">26791724</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burkhart</surname><given-names>B. J.</given-names></name><name><surname>Hudson</surname><given-names>G. A.</given-names></name><name><surname>Dunbar</surname><given-names>K. L.</given-names></name><name><surname>Mitchell</surname><given-names>D. A.</given-names></name></person-group> (<year>2015</year>). <article-title>A prevalent peptide-binding domain guides ribosomal natural product biosynthesis.</article-title>
<source><italic>Nat. Chem. Biol.</italic></source>
<volume>11</volume>
<fpage>564</fpage>&#x02013;<lpage>570</lpage>. <pub-id pub-id-type="doi">10.1038/nchembio.1856</pub-id>
<?supplied-pmid 26167873?><pub-id pub-id-type="pmid">26167873</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burkhart</surname><given-names>B. J.</given-names></name><name><surname>Schwalen</surname><given-names>C. J.</given-names></name><name><surname>Mann</surname><given-names>G.</given-names></name><name><surname>Naismith</surname><given-names>J. H.</given-names></name><name><surname>Mitchell</surname><given-names>D. A.</given-names></name></person-group> (<year>2017</year>). <article-title>YcaO-dependent posttranslational amide activation: biosynthesis.</article-title>
<source><italic>Struct. Funct. Chem. Rev.</italic></source>
<volume>117</volume>
<fpage>5389</fpage>&#x02013;<lpage>5456</lpage>. <pub-id pub-id-type="doi">10.1021/acs.chemrev.6b00623</pub-id>
<?supplied-pmid 28256131?><pub-id pub-id-type="pmid">28256131</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chatterjee</surname><given-names>C.</given-names></name><name><surname>Paul</surname><given-names>M.</given-names></name><name><surname>Xie</surname><given-names>L.</given-names></name><name><surname>van der Donk</surname><given-names>W. A.</given-names></name></person-group> (<year>2005</year>). <article-title>Biosynthesis and mode of action of lantibiotics.</article-title>
<source><italic>Chem. Rev.</italic></source>
<volume>105</volume>
<fpage>633</fpage>&#x02013;<lpage>684</lpage>. <pub-id pub-id-type="doi">10.1021/cr030105v</pub-id>
<?supplied-pmid 15700960?><pub-id pub-id-type="pmid">15700960</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chopra</surname><given-names>L.</given-names></name><name><surname>Singh</surname><given-names>G.</given-names></name><name><surname>Choudhary</surname><given-names>V.</given-names></name><name><surname>Sahoo</surname><given-names>D. K.</given-names></name></person-group> (<year>2014</year>). <article-title>Sonorensin: an antimicrobial peptide, belonging to the heterocycloanthracin subfamily of bacteriocins, from a new marine isolate, Bacillus sonorensis MT93.</article-title>
<source><italic>Appl. Environ. Microbiol.</italic></source>
<volume>80</volume>
<fpage>2981</fpage>&#x02013;<lpage>2990</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.04259-13</pub-id>
<?supplied-pmid 24610839?><pub-id pub-id-type="pmid">24610839</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clough</surname><given-names>B.</given-names></name><name><surname>Strath</surname><given-names>M.</given-names></name><name><surname>Preiser</surname><given-names>P.</given-names></name><name><surname>Denny</surname><given-names>P.</given-names></name><name><surname>Wilson</surname><given-names>I. R.</given-names></name></person-group> (<year>1997</year>). <article-title>Thiostrepton binds to malarial plastid rRNA.</article-title>
<source><italic>FEBS Lett.</italic></source>
<volume>406</volume>
<fpage>123</fpage>&#x02013;<lpage>125</lpage>. <pub-id pub-id-type="doi">10.1016/s0014-5793(97)00241-x</pub-id><pub-id pub-id-type="pmid">9109400</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cotter</surname><given-names>P. D.</given-names></name><name><surname>Draper</surname><given-names>L. A.</given-names></name><name><surname>Lawton</surname><given-names>E. M.</given-names></name><name><surname>Daly</surname><given-names>K. M.</given-names></name><name><surname>Groeger</surname><given-names>D. S.</given-names></name><name><surname>Casey</surname><given-names>P. G.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title>Listeriolysin S, a novel peptide haemolysin associated with a subset of lineage I <italic>Listeria monocytogenes</italic>.</article-title>
<source><italic>PLoS Pathog.</italic></source>
<volume>4</volume>:<issue>e1000144</issue>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1000144</pub-id>
<?supplied-pmid 18787690?><pub-id pub-id-type="pmid">18787690</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname><given-names>C. L.</given-names></name><name><surname>Doroghazi</surname><given-names>J. R.</given-names></name><name><surname>Mitchell</surname><given-names>D. A.</given-names></name></person-group> (<year>2015</year>). <article-title>The genomic landscape of ribosomal peptides containing thiazole and oxazole heterocycles.</article-title>
<source><italic>BMC Genomics</italic></source>
<volume>16</volume>:<issue>778</issue>. <pub-id pub-id-type="doi">10.1186/s12864-015-2008-0</pub-id>
<?supplied-pmid 26462797?><pub-id pub-id-type="pmid">26462797</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crone</surname><given-names>W. J. K.</given-names></name><name><surname>Vior</surname><given-names>N. M.</given-names></name><name><surname>Santos-Aberturas</surname><given-names>J.</given-names></name><name><surname>Schmitz</surname><given-names>L. G.</given-names></name><name><surname>Leeper</surname><given-names>F. J.</given-names></name><name><surname>Truman</surname><given-names>A. W.</given-names></name></person-group> (<year>2016</year>). <article-title>Dissecting bottromycin biosynthesis using comparative untargeted metabolomics.</article-title>
<source><italic>Angew. Chem. Int. Ed.</italic></source>
<volume>55</volume>
<fpage>9639</fpage>&#x02013;<lpage>9643</lpage>. <pub-id pub-id-type="doi">10.1002/anie.201604304</pub-id>
<?supplied-pmid 27374993?><pub-id pub-id-type="pmid">27374993</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delgado</surname><given-names>M. A.</given-names></name><name><surname>Rintoul</surname><given-names>M. R.</given-names></name><name><surname>Far&#x000ed;as</surname><given-names>R. N.</given-names></name><name><surname>Salom&#x000f3;n</surname><given-names>R. A.</given-names></name></person-group> (<year>2001</year>). <article-title><italic>Escherichia coli</italic> RNA polymerase is the target of the cyclopeptide antibiotic microcin J25.</article-title>
<source><italic>J. Bacteriol.</italic></source>
<volume>183</volume>
<fpage>4543</fpage>&#x02013;<lpage>4550</lpage>. <pub-id pub-id-type="doi">10.1128/JB.183.15.4543-4550.2001</pub-id>
<?supplied-pmid 11443089?><pub-id pub-id-type="pmid">11443089</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>W.</given-names></name><name><surname>Liu</surname><given-names>W.-Q.</given-names></name><name><surname>Jia</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>van der Donk</surname><given-names>W. A.</given-names></name><name><surname>Zhang</surname><given-names>Q.</given-names></name></person-group> (<year>2016</year>). <article-title>Biosynthetic investigation of phomopsins reveals a widespread pathway for ribosomal natural products in Ascomycetes.</article-title>
<source><italic>Proc. Natl. Acad. Sci. U.S.A.</italic></source>
<volume>113</volume>
<fpage>3521</fpage>&#x02013;<lpage>3526</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1522907113</pub-id>
<?supplied-pmid 26979951?><pub-id pub-id-type="pmid">26979951</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>S.-H.</given-names></name><name><surname>Kulikovsky</surname><given-names>A.</given-names></name><name><surname>Zukher</surname><given-names>I.</given-names></name><name><surname>Estrada</surname><given-names>P.</given-names></name><name><surname>Dubiley</surname><given-names>S.</given-names></name><name><surname>Severinov</surname><given-names>K.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Biosynthesis of the RiPP trojan horse nucleotide antibiotic microcin C is directed by the N-formyl of the peptide precursor.</article-title>
<source><italic>Chem. Sci.</italic></source>
<volume>10</volume>
<fpage>2391</fpage>&#x02013;<lpage>2395</lpage>. <pub-id pub-id-type="doi">10.1039/c8sc03173h</pub-id>
<?supplied-pmid 30881667?><pub-id pub-id-type="pmid">30881667</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunbar</surname><given-names>K. L.</given-names></name><name><surname>Melby</surname><given-names>J. O.</given-names></name><name><surname>Mitchell</surname><given-names>D. A.</given-names></name></person-group> (<year>2012</year>). <article-title>YcaO domains use ATP to activate amide backbones during peptide cyclodehydrations.</article-title>
<source><italic>Nat. Chem. Biol.</italic></source>
<volume>8</volume>
<fpage>569</fpage>&#x02013;<lpage>575</lpage>. <pub-id pub-id-type="doi">10.1038/nchembio.944</pub-id>
<?supplied-pmid 22522320?><pub-id pub-id-type="pmid">22522320</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunbar</surname><given-names>K. L.</given-names></name><name><surname>Mitchell</surname><given-names>D. A.</given-names></name></person-group> (<year>2013</year>). <article-title>Insights into the mechanism of peptide cyclodehydrations achieved through the chemoenzymatic generation of amide derivatives.</article-title>
<source><italic>J. Am. Chem. Soc.</italic></source>
<volume>135</volume>
<fpage>8692</fpage>&#x02013;<lpage>8701</lpage>. <pub-id pub-id-type="doi">10.1021/ja4029507</pub-id>
<?supplied-pmid 23721104?><pub-id pub-id-type="pmid">23721104</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunbar</surname><given-names>K. L.</given-names></name><name><surname>Tietz</surname><given-names>J. I.</given-names></name><name><surname>Cox</surname><given-names>C. L.</given-names></name><name><surname>Burkhart</surname><given-names>B. J.</given-names></name><name><surname>Mitchell</surname><given-names>D. A.</given-names></name></person-group> (<year>2015</year>). <article-title>Identification of an auxiliary leader peptide-binding protein required for azoline formation in ribosomal natural products.</article-title>
<source><italic>J. Am. Chem. Soc.</italic></source>
<volume>137</volume>
<fpage>7672</fpage>&#x02013;<lpage>7677</lpage>. <pub-id pub-id-type="doi">10.1021/jacs.5b04682</pub-id>
<?supplied-pmid 26024319?><pub-id pub-id-type="pmid">26024319</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eyles</surname><given-names>T. H.</given-names></name><name><surname>Vior</surname><given-names>N. M.</given-names></name><name><surname>Truman</surname><given-names>A. W.</given-names></name></person-group> (<year>2018</year>). <article-title>Rapid and robust yeast-mediated pathway refactoring generates multiple new bottromycin-related metabolites.</article-title>
<source><italic>ACS Synth. Biol.</italic></source>
<volume>7</volume>
<fpage>1211</fpage>&#x02013;<lpage>1218</lpage>. <pub-id pub-id-type="doi">10.1021/acssynbio.8b00038</pub-id>
<?supplied-pmid 29694038?><pub-id pub-id-type="pmid">29694038</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Franz</surname><given-names>L.</given-names></name><name><surname>Adam</surname><given-names>S.</given-names></name><name><surname>Santos-Aberturas</surname><given-names>J.</given-names></name><name><surname>Truman</surname><given-names>A. W.</given-names></name><name><surname>Koehnke</surname><given-names>J.</given-names></name></person-group> (<year>2017</year>). <article-title>Macroamidine formation in bottromycins is catalyzed by a divergent YcaO enzyme.</article-title>
<source><italic>J. Am. Chem. Soc.</italic></source>
<volume>139</volume>
<fpage>18158</fpage>&#x02013;<lpage>18161</lpage>. <pub-id pub-id-type="doi">10.1021/jacs.7b09898</pub-id>
<?supplied-pmid 29206037?><pub-id pub-id-type="pmid">29206037</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gagnon</surname><given-names>M. G.</given-names></name><name><surname>Roy</surname><given-names>R. N.</given-names></name><name><surname>Lomakin</surname><given-names>I. B.</given-names></name><name><surname>Florin</surname><given-names>T.</given-names></name><name><surname>Mankin</surname><given-names>A. S.</given-names></name><name><surname>Steitz</surname><given-names>T. A.</given-names></name></person-group> (<year>2016</year>). <article-title>Structures of proline-rich peptides bound to the ribosome reveal a common mechanism of protein synthesis inhibition.</article-title>
<source><italic>Nucleic Acids Res.</italic></source>
<volume>44</volume>
<fpage>2439</fpage>&#x02013;<lpage>2450</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkw018</pub-id>
<?supplied-pmid 26809677?><pub-id pub-id-type="pmid">26809677</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaillard</surname><given-names>T.</given-names></name><name><surname>Madamet</surname><given-names>M.</given-names></name><name><surname>Tsombeng</surname><given-names>F. F.</given-names></name><name><surname>Dormoi</surname><given-names>J.</given-names></name><name><surname>Pradines</surname><given-names>B.</given-names></name></person-group> (<year>2016</year>). <article-title>Antibiotics in malaria therapy: which antibiotics except tetracyclines and macrolides may be used against malaria?</article-title>
<source><italic>Malar. J.</italic></source>
<volume>15</volume>:<issue>556</issue>. <pub-id pub-id-type="doi">10.1186/s12936-016-1613-y</pub-id>
<?supplied-pmid 27846898?><pub-id pub-id-type="pmid">27846898</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghilarov</surname><given-names>D.</given-names></name><name><surname>Stevenson</surname><given-names>C. E. M.</given-names></name><name><surname>Travin</surname><given-names>D. Y.</given-names></name><name><surname>Piskunova</surname><given-names>J.</given-names></name><name><surname>Serebryakova</surname><given-names>M.</given-names></name><name><surname>Maxwell</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Architecture of microcin B17 synthetase: an octameric protein complex converting a ribosomally synthesized peptide into a DNA gyrase poison.</article-title>
<source><italic>Mol. Cell</italic></source>
<volume>73</volume>
<fpage>749</fpage>&#x02013;<lpage>762</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2018.11.032</pub-id>
<?supplied-pmid 30661981?><pub-id pub-id-type="pmid">30661981</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghodge</surname><given-names>S. V.</given-names></name><name><surname>Biernat</surname><given-names>K. A.</given-names></name><name><surname>Bassett</surname><given-names>S. J.</given-names></name><name><surname>Redinbo</surname><given-names>M. R.</given-names></name><name><surname>Bowers</surname><given-names>A. A.</given-names></name></person-group> (<year>2016</year>). <article-title>Post-translational claisen condensation and decarboxylation en route to the bicyclic core of pantocin A.</article-title>
<source><italic>J. Am. Chem. Soc.</italic></source>
<volume>138</volume>
<fpage>5487</fpage>&#x02013;<lpage>5490</lpage>. <pub-id pub-id-type="doi">10.1021/jacs.5b13529</pub-id>
<?supplied-pmid 27088303?><pub-id pub-id-type="pmid">27088303</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez</surname><given-names>D. J.</given-names></name><name><surname>Lee</surname><given-names>S. W.</given-names></name><name><surname>Hensler</surname><given-names>M. E.</given-names></name><name><surname>Markley</surname><given-names>A. L.</given-names></name><name><surname>Dahesh</surname><given-names>S.</given-names></name><name><surname>Mitchell</surname><given-names>D. A.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Clostridiolysin S, a post-translationally modified biotoxin from Clostridium botulinum.</article-title>
<source><italic>J. Biol. Chem.</italic></source>
<volume>285</volume>
<fpage>28220</fpage>&#x02013;<lpage>28228</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M110.118554</pub-id>
<?supplied-pmid 20581111?><pub-id pub-id-type="pmid">20581111</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez</surname><given-names>R. L.</given-names></name><name><surname>Chu</surname><given-names>S.</given-names></name><name><surname>Puglisi</surname><given-names>J. D.</given-names></name></person-group> (<year>2007</year>). <article-title>Thiostrepton inhibition of tRNA delivery to the ribosome.</article-title>
<source><italic>RNA</italic></source>
<volume>13</volume>
<fpage>2091</fpage>&#x02013;<lpage>2097</lpage>. <pub-id pub-id-type="doi">10.1261/rna.499407</pub-id>
<?supplied-pmid 17951333?><pub-id pub-id-type="pmid">17951333</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>W.</given-names></name><name><surname>Sardar</surname><given-names>D.</given-names></name><name><surname>Pierce</surname><given-names>E.</given-names></name><name><surname>Schmidt</surname><given-names>E. W.</given-names></name></person-group> (<year>2018</year>). <article-title>Roads to rome: role of multiple cassettes in cyanobactin ripp biosynthesis.</article-title>
<source><italic>J. Am. Chem. Soc.</italic></source>
<volume>140</volume>
<fpage>16213</fpage>&#x02013;<lpage>16221</lpage>. <pub-id pub-id-type="doi">10.1021/jacs.8b09328</pub-id>
<?supplied-pmid 30387998?><pub-id pub-id-type="pmid">30387998</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haft</surname><given-names>D. H.</given-names></name></person-group> (<year>2009</year>). <article-title>A strain-variable bacteriocin in <italic>Bacillus anthracis</italic> and <italic>Bacillus cereus</italic> with repeated Cys-Xaa-Xaa motifs.</article-title>
<source><italic>Biol. Direct.</italic></source>
<volume>4</volume>:<issue>15</issue>. <pub-id pub-id-type="doi">10.1186/1745-6150-4-15</pub-id>
<?supplied-pmid 19383135?><pub-id pub-id-type="pmid">19383135</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harms</surname><given-names>J. M.</given-names></name><name><surname>Wilson</surname><given-names>D. N.</given-names></name><name><surname>Schluenzen</surname><given-names>F.</given-names></name><name><surname>Connell</surname><given-names>S. R.</given-names></name><name><surname>Stachelhaus</surname><given-names>T.</given-names></name><name><surname>Zaborowska</surname><given-names>Z.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title>Translational regulation via L11: molecular switches on the ribosome turned on and off by Thiostrepton and Micrococcin.</article-title>
<source><italic>Mol. Cell</italic></source>
<volume>30</volume>
<fpage>26</fpage>&#x02013;<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2008.01.009</pub-id>
<?supplied-pmid 18406324?><pub-id pub-id-type="pmid">18406324</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayashi</surname><given-names>S.</given-names></name><name><surname>Ozaki</surname><given-names>T.</given-names></name><name><surname>Asamizu</surname><given-names>S.</given-names></name><name><surname>Ikeda</surname><given-names>H.</given-names></name><name><surname>&#x000d4;mura</surname><given-names>S.</given-names></name><name><surname>Oku</surname><given-names>N.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Genome mining reveals a minimum gene set for the biosynthesis of 32-membered macrocyclic thiopeptides lactazoles.</article-title>
<source><italic>Chem. Biol.</italic></source>
<volume>21</volume>
<fpage>679</fpage>&#x02013;<lpage>688</lpage>. <pub-id pub-id-type="doi">10.1016/j.chembiol.2014.03.008</pub-id>
<?supplied-pmid 24768308?><pub-id pub-id-type="pmid">24768308</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heddle</surname><given-names>J. G.</given-names></name><name><surname>Blance</surname><given-names>S. J.</given-names></name><name><surname>Zamble</surname><given-names>D. B.</given-names></name><name><surname>Hollfelder</surname><given-names>F.</given-names></name><name><surname>Miller</surname><given-names>D. A.</given-names></name><name><surname>Wentzell</surname><given-names>L. M.</given-names></name><etal/></person-group> (<year>2001</year>). <article-title>The antibiotic microcin B17 is a DNA gyrase poison: characterisation of the mode of inhibition.</article-title>
<source><italic>J. Mol. Biol.</italic></source>
<volume>307</volume>
<fpage>1223</fpage>&#x02013;<lpage>1234</lpage>. <pub-id pub-id-type="doi">10.1006/jmbi.2001.4562</pub-id>
<?supplied-pmid 11292337?><pub-id pub-id-type="pmid">11292337</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heffron</surname><given-names>S. E.</given-names></name><name><surname>Jurnak</surname><given-names>F.</given-names></name></person-group> (<year>2000</year>). <article-title>Structure of an EF-Tu complex with a thiazolyl peptide antibiotic determined at 2.<italic>35</italic> a resolution: atomic basis for GE2270A inhibition of EF-Tu.</article-title>
<source><italic>Biochemistry</italic></source>
<volume>39</volume>
<fpage>37</fpage>&#x02013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1021/bi9913597</pub-id>
<?supplied-pmid 10625477?><pub-id pub-id-type="pmid">10625477</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hegde</surname><given-names>S. S.</given-names></name><name><surname>Vetting</surname><given-names>M. W.</given-names></name><name><surname>Roderick</surname><given-names>S. L.</given-names></name><name><surname>Mitchenall</surname><given-names>L. A.</given-names></name><name><surname>Maxwell</surname><given-names>A.</given-names></name><name><surname>Takiff</surname><given-names>H. E.</given-names></name><etal/></person-group> (<year>2005</year>). <article-title>A fluoroquinolone resistance protein from <italic>Mycobacterium tuberculosis</italic> that mimics DNA.</article-title>
<source><italic>Science</italic></source>
<volume>308</volume>
<fpage>1480</fpage>&#x02013;<lpage>1483</lpage>. <pub-id pub-id-type="doi">10.1126/science.1110699</pub-id>
<?supplied-pmid 15933203?><pub-id pub-id-type="pmid">15933203</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hudson</surname><given-names>G. A.</given-names></name><name><surname>Burkhart</surname><given-names>B. J.</given-names></name><name><surname>DiCaprio</surname><given-names>A. J.</given-names></name><name><surname>Schwalen</surname><given-names>C. J.</given-names></name><name><surname>Kille</surname><given-names>B.</given-names></name><name><surname>Pogorelov</surname><given-names>T. V.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Bioinformatic mapping of radical s-adenosylmethionine-dependent ribosomally synthesized and post-translationally modified peptides identifies new C&#x003b1;, C&#x003b2;, and C&#x003b3;-linked thioether-containing peptides.</article-title>
<source><italic>J. Am. Chem. Soc.</italic></source>
<volume>141</volume>
<fpage>8228</fpage>&#x02013;<lpage>8238</lpage>. <pub-id pub-id-type="doi">10.1021/jacs.9b01519</pub-id>
<?supplied-pmid 31059252?><pub-id pub-id-type="pmid">31059252</pub-id></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hudson</surname><given-names>G. A.</given-names></name><name><surname>Zhang</surname><given-names>Z.</given-names></name><name><surname>Tietz</surname><given-names>J. I.</given-names></name><name><surname>Mitchell</surname><given-names>D. A.</given-names></name><name><surname>van der Donk</surname><given-names>W. A.</given-names></name></person-group> (<year>2015</year>). <article-title>In vitro biosynthesis of the core scaffold of the <italic>Thiopeptide Thiomuracin</italic>.</article-title>
<source><italic>J. Am. Chem. Soc.</italic></source>
<volume>137</volume>
<fpage>16012</fpage>&#x02013;<lpage>16015</lpage>. <pub-id pub-id-type="doi">10.1021/jacs.5b10194</pub-id>
<?supplied-pmid 26675417?><pub-id pub-id-type="pmid">26675417</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huo</surname><given-names>L.</given-names></name><name><surname>Rachid</surname><given-names>S.</given-names></name><name><surname>Stadler</surname><given-names>M.</given-names></name><name><surname>Wenzel</surname><given-names>S. C.</given-names></name><name><surname>M&#x000fc;ller</surname><given-names>R.</given-names></name></person-group> (<year>2012</year>). <article-title>Synthetic biotechnology to study and engineer ribosomal bottromycin biosynthesis.</article-title>
<source><italic>Chem. Biol.</italic></source>
<volume>19</volume>
<fpage>1278</fpage>&#x02013;<lpage>1287</lpage>. <pub-id pub-id-type="doi">10.1016/j.chembiol.2012.08.013</pub-id>
<?supplied-pmid 23021914?><pub-id pub-id-type="pmid">23021914</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jarrad</surname><given-names>A. M.</given-names></name><name><surname>Karoli</surname><given-names>T.</given-names></name><name><surname>Blaskovich</surname><given-names>M. A. T.</given-names></name><name><surname>Lyras</surname><given-names>D.</given-names></name><name><surname>Cooper</surname><given-names>M. A.</given-names></name></person-group> (<year>2015</year>). <article-title>Clostridium difficile drug pipeline: challenges in discovery and development of new agents.</article-title>
<source><italic>J. Med. Chem.</italic></source>
<volume>58</volume>
<fpage>5164</fpage>&#x02013;<lpage>5185</lpage>. <pub-id pub-id-type="doi">10.1021/jm5016846</pub-id>
<?supplied-pmid 25760275?><pub-id pub-id-type="pmid">25760275</pub-id></mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeon</surname><given-names>B. S.</given-names></name><name><surname>Wang</surname><given-names>S. A.</given-names></name><name><surname>Ruszczycky</surname><given-names>M. W.</given-names></name><name><surname>Liu</surname><given-names>H. W.</given-names></name></person-group> (<year>2017</year>). <article-title>Natural [4 + 2]-Cyclases.</article-title>
<source><italic>Chem. Rev.</italic></source>
<volume>117</volume>
<fpage>5367</fpage>&#x02013;<lpage>5388</lpage>. <pub-id pub-id-type="doi">10.1021/acs.chemrev.6b00578</pub-id>
<?supplied-pmid 28441874?><pub-id pub-id-type="pmid">28441874</pub-id></mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Just-Baringo</surname><given-names>X.</given-names></name><name><surname>Albericio</surname><given-names>F.</given-names></name><name><surname>&#x000c1;lvarez</surname><given-names>M.</given-names></name></person-group> (<year>2014</year>). <article-title>Thiopeptide antibiotics: retrospective and recent advances.</article-title>
<source><italic>Mar. Drugs</italic></source>
<volume>12</volume>
<fpage>317</fpage>&#x02013;<lpage>351</lpage>. <pub-id pub-id-type="doi">10.3390/md12010317</pub-id>
<?supplied-pmid 24445304?><pub-id pub-id-type="pmid">24445304</pub-id></mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kautsar</surname><given-names>S. A.</given-names></name><name><surname>Blin</surname><given-names>K.</given-names></name><name><surname>Shaw</surname><given-names>S.</given-names></name><name><surname>Navarro-Mu&#x000f1;oz</surname><given-names>J. C.</given-names></name><name><surname>Terlouw</surname><given-names>B. R.</given-names></name><name><surname>van der Hooft</surname><given-names>J. J. J.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>MIBiG 2.0: a repository for biosynthetic gene clusters of known function.</article-title>
<source><italic>Nucleic Acids Res.</italic></source>
<volume>48</volume>
<fpage>D454</fpage>&#x02013;<lpage>D458</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkz882</pub-id>
<?supplied-pmid 31612915?><pub-id pub-id-type="pmid">31612915</pub-id></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kazakov</surname><given-names>T.</given-names></name><name><surname>Vondenhoff</surname><given-names>G. H.</given-names></name><name><surname>Datsenko</surname><given-names>K. A.</given-names></name><name><surname>Novikova</surname><given-names>M.</given-names></name><name><surname>Metlitskaya</surname><given-names>A.</given-names></name><name><surname>Wanner</surname><given-names>B. L.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title><italic>Escherichia coli</italic> peptidase A, B, or N can process translation inhibitor microcin C.</article-title>
<source><italic>J. Bacteriol.</italic></source>
<volume>190</volume>
<fpage>2607</fpage>&#x02013;<lpage>2610</lpage>. <pub-id pub-id-type="doi">10.1128/JB.01956-07</pub-id>
<?supplied-pmid 18223070?><pub-id pub-id-type="pmid">18223070</pub-id></mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kulikovsky</surname><given-names>A.</given-names></name><name><surname>Serebryakova</surname><given-names>M.</given-names></name><name><surname>Bantysh</surname><given-names>O.</given-names></name><name><surname>Metlitskaya</surname><given-names>A.</given-names></name><name><surname>Borukhov</surname><given-names>S.</given-names></name><name><surname>Severinov</surname><given-names>K.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>The molecular mechanism of aminopropylation of peptide-nucleotide antibiotic microcin C.</article-title>
<source><italic>J. Am. Chem. Soc.</italic></source>
<volume>136</volume>
<fpage>11168</fpage>&#x02013;<lpage>11175</lpage>. <pub-id pub-id-type="doi">10.1021/ja505982c</pub-id>
<?supplied-pmid 25026542?><pub-id pub-id-type="pmid">25026542</pub-id></mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J.</given-names></name><name><surname>Hao</surname><given-names>Y.</given-names></name><name><surname>Blair</surname><given-names>P. M.</given-names></name><name><surname>Melby</surname><given-names>J. O.</given-names></name><name><surname>Agarwal</surname><given-names>V.</given-names></name><name><surname>Burkhart</surname><given-names>B. J.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Structural and functional insight into an unexpectedly selective N-methyltransferase involved in plantazolicin biosynthesis.</article-title>
<source><italic>Proc. Natl. Acad. Sci. U.S.A.</italic></source>
<volume>110</volume>
<fpage>12954</fpage>&#x02013;<lpage>12959</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1306101110</pub-id>
<?supplied-pmid 23878226?><pub-id pub-id-type="pmid">23878226</pub-id></mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Qu</surname><given-names>X.</given-names></name><name><surname>He</surname><given-names>X.</given-names></name><name><surname>Duan</surname><given-names>L.</given-names></name><name><surname>Wu</surname><given-names>G.</given-names></name><name><surname>Bi</surname><given-names>D.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>ThioFinder: a web-based tool for the identification of thiopeptide gene clusters in DNA sequences.</article-title>
<source><italic>PLoS One</italic></source>
<volume>7</volume>:<issue>e45878</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0045878</pub-id>
<?supplied-pmid 23029291?><pub-id pub-id-type="pmid">23029291</pub-id></mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J. W.-H.</given-names></name><name><surname>Vederas</surname><given-names>J. C.</given-names></name></person-group> (<year>2009</year>). <article-title>Drug discovery and natural products: end of an era or an endless frontier?</article-title>
<source><italic>Science</italic></source>
<volume>325</volume>
<fpage>161</fpage>&#x02013;<lpage>165</lpage>. <pub-id pub-id-type="doi">10.1126/science.1168243</pub-id>
<?supplied-pmid 19589993?><pub-id pub-id-type="pmid">19589993</pub-id></mixed-citation></ref><ref id="B51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y. M.</given-names></name><name><surname>Milne</surname><given-names>J. C.</given-names></name><name><surname>Madison</surname><given-names>L. L.</given-names></name><name><surname>Kolter</surname><given-names>R.</given-names></name><name><surname>Walsh</surname><given-names>C. T.</given-names></name></person-group> (<year>1996</year>). <article-title>From peptide precursors to oxazole and thiazole-containing peptide antibiotics: microcin B17 synthase.</article-title>
<source><italic>Science</italic></source>
<volume>274</volume>
<fpage>1188</fpage>&#x02013;<lpage>1193</lpage>. <pub-id pub-id-type="doi">10.1126/science.274.5290.1188</pub-id>
<?supplied-pmid 8895467?><pub-id pub-id-type="pmid">8895467</pub-id></mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>N.</given-names></name><name><surname>Song</surname><given-names>L.</given-names></name><name><surname>Liu</surname><given-names>M.</given-names></name><name><surname>Shang</surname><given-names>F.</given-names></name><name><surname>Anderson</surname><given-names>Z.</given-names></name><name><surname>Fox</surname><given-names>D. J.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Unique post-translational oxime formation in the biosynthesis of the azolemycin complex of novel ribosomal peptides from <italic>Streptomyces</italic> sp. FXJ1.264.</article-title>
<source><italic>Chem. Sci.</italic></source>
<volume>7</volume>
<fpage>482</fpage>&#x02013;<lpage>488</lpage>. <pub-id pub-id-type="doi">10.1039/c5sc03021h</pub-id>
<?supplied-pmid 30123457?><pub-id pub-id-type="pmid">28791101</pub-id></mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahanta</surname><given-names>N.</given-names></name><name><surname>Liu</surname><given-names>A.</given-names></name><name><surname>Dong</surname><given-names>S.</given-names></name><name><surname>Nair</surname><given-names>S. K.</given-names></name><name><surname>Mitchell</surname><given-names>D. A.</given-names></name></person-group> (<year>2018</year>). <article-title>Enzymatic reconstitution of ribosomal peptide backbone thioamidation.</article-title>
<source><italic>Proc. Natl. Acad. Sci. U.S.A.</italic></source>
<volume>2017</volume>
<issue>22324</issue>. <pub-id pub-id-type="doi">10.1073/pnas.1722324115</pub-id>
<?supplied-pmid 29507203?><pub-id pub-id-type="pmid">29507203</pub-id></mixed-citation></ref><ref id="B54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mann</surname><given-names>G.</given-names></name><name><surname>Huo</surname><given-names>L.</given-names></name><name><surname>Adam</surname><given-names>S.</given-names></name><name><surname>Nardone</surname><given-names>B.</given-names></name><name><surname>Vendome</surname><given-names>J.</given-names></name><name><surname>Westwood</surname><given-names>N. J.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Structure and substrate recognition of the bottromycin maturation enzyme BotP.</article-title>
<source><italic>Chembiochem</italic></source>
<volume>17</volume>
<fpage>2286</fpage>&#x02013;<lpage>2292</lpage>. <pub-id pub-id-type="doi">10.1002/cbic.201600406</pub-id>
<?supplied-pmid 27653442?><pub-id pub-id-type="pmid">27653442</pub-id></mixed-citation></ref><ref id="B55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melby</surname><given-names>J. O.</given-names></name><name><surname>Dunbar</surname><given-names>K. L.</given-names></name><name><surname>Trinh</surname><given-names>N. Q.</given-names></name><name><surname>Mitchell</surname><given-names>D. A.</given-names></name></person-group> (<year>2012</year>). <article-title>Selectivity, directionality, and promiscuity in peptide processing from a bacillus sp. <italic>Al Hakam cyclodehydratase</italic>.</article-title>
<source><italic>J. Am. Chem. Soc.</italic></source>
<volume>134</volume>
<fpage>5309</fpage>&#x02013;<lpage>5316</lpage>. <pub-id pub-id-type="doi">10.1021/ja211675n</pub-id>
<?supplied-pmid 22401305?><pub-id pub-id-type="pmid">22401305</pub-id></mixed-citation></ref><ref id="B56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Metelev</surname><given-names>M.</given-names></name><name><surname>Osterman</surname><given-names>I. A.</given-names></name><name><surname>Ghilarov</surname><given-names>D.</given-names></name><name><surname>Khabibullina</surname><given-names>N. F.</given-names></name><name><surname>Yakimov</surname><given-names>A.</given-names></name><name><surname>Shabalin</surname><given-names>K.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Klebsazolicin inhibits 70S ribosome by obstructing the peptide exit tunnel.</article-title>
<source><italic>Nat. Chem. Biol.</italic></source>
<volume>13</volume>
<fpage>1129</fpage>&#x02013;<lpage>1136</lpage>. <pub-id pub-id-type="doi">10.1038/nchembio.2462</pub-id>
<?supplied-pmid 28846667?><pub-id pub-id-type="pmid">28846667</pub-id></mixed-citation></ref><ref id="B57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Metelev</surname><given-names>M.</given-names></name><name><surname>Serebryakova</surname><given-names>M.</given-names></name><name><surname>Ghilarov</surname><given-names>D.</given-names></name><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Severinov</surname><given-names>K.</given-names></name></person-group> (<year>2013</year>). <article-title>Structure of microcin B-like compounds produced by <italic>Pseudomonas</italic> syringae and species specificity of their antibacterial action.</article-title>
<source><italic>J. Bacteriol.</italic></source>
<volume>195</volume>
<fpage>4129</fpage>&#x02013;<lpage>4137</lpage>. <pub-id pub-id-type="doi">10.1128/JB.00665-13</pub-id>
<?supplied-pmid 23852863?><pub-id pub-id-type="pmid">23852863</pub-id></mixed-citation></ref><ref id="B58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Metlitskaya</surname><given-names>A.</given-names></name><name><surname>Kazakov</surname><given-names>T.</given-names></name><name><surname>Kommer</surname><given-names>A.</given-names></name><name><surname>Pavlova</surname><given-names>O.</given-names></name><name><surname>Praetorius-Ibba</surname><given-names>M.</given-names></name><name><surname>Ibba</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>Aspartyl-tRNA synthetase is the target of peptide nucleotide antibiotic Microcin C.</article-title>
<source><italic>J. Biol. Chem.</italic></source>
<volume>281</volume>
<fpage>18033</fpage>&#x02013;<lpage>18042</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M513174200</pub-id>
<?supplied-pmid 16574659?><pub-id pub-id-type="pmid">16574659</pub-id></mixed-citation></ref><ref id="B59"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mirdita</surname><given-names>M.</given-names></name><name><surname>Steinegger</surname><given-names>M.</given-names></name><name><surname>S&#x000f6;ding</surname><given-names>J.</given-names></name></person-group> (<year>2019</year>). <article-title>MMseqs2 desktop and local web server app for fast, interactive sequence searches.</article-title>
<source><italic>Bioinformatics</italic></source>
<volume>35</volume>
<fpage>2856</fpage>&#x02013;<lpage>2858</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/bty1057</pub-id>
<?supplied-pmid 30615063?><pub-id pub-id-type="pmid">30615063</pub-id></mixed-citation></ref><ref id="B60"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molloy</surname><given-names>E. M.</given-names></name><name><surname>Cotter</surname><given-names>P. D.</given-names></name><name><surname>Hill</surname><given-names>C.</given-names></name><name><surname>Mitchell</surname><given-names>D. A.</given-names></name><name><surname>Ross</surname><given-names>R. P.</given-names></name></person-group> (<year>2011</year>). <article-title>Streptolysin S-like virulence factors: the continuing sagA.</article-title>
<source><italic>Nat. Rev. Microbiol.</italic></source>
<volume>9</volume>
<fpage>670</fpage>&#x02013;<lpage>681</lpage>. <pub-id pub-id-type="doi">10.1038/nrmicro2624</pub-id>
<?supplied-pmid 21822292?><pub-id pub-id-type="pmid">21822292</pub-id></mixed-citation></ref><ref id="B61"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moloney</surname><given-names>M. G.</given-names></name></person-group> (<year>2016</year>). <article-title>Natural products as a source for novel antibiotics.</article-title>
<source><italic>Trends Pharmacol. Sci.</italic></source>
<volume>37</volume>
<fpage>689</fpage>&#x02013;<lpage>701</lpage>. <pub-id pub-id-type="doi">10.1016/j.tips.2016.05.001</pub-id>
<?supplied-pmid 27267698?><pub-id pub-id-type="pmid">27267698</pub-id></mixed-citation></ref><ref id="B62"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Navarro-Mu&#x000f1;oz</surname><given-names>J. C.</given-names></name><name><surname>Selem-Mojica</surname><given-names>N.</given-names></name><name><surname>Mullowney</surname><given-names>M. W.</given-names></name><name><surname>Kautsar</surname><given-names>S. A.</given-names></name><name><surname>Tryon</surname><given-names>J. H.</given-names></name><name><surname>Parkinson</surname><given-names>E. I.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>A computational framework to explore large-scale biosynthetic diversity.</article-title>
<source><italic>Nat. Chem. Biol.</italic></source>
<volume>16</volume>
<fpage>60</fpage>&#x02013;<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1038/s41589-019-0400-9</pub-id>
<?supplied-pmid 31768033?><pub-id pub-id-type="pmid">31768033</pub-id></mixed-citation></ref><ref id="B63"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nissen</surname><given-names>P.</given-names></name><name><surname>Thirup</surname><given-names>S.</given-names></name><name><surname>Kjeldgaard</surname><given-names>M.</given-names></name><name><surname>Nyborg</surname><given-names>J.</given-names></name></person-group> (<year>1999</year>). <article-title>The crystal structure of Cys-tRNACys-EF-Tu-GDPNP reveals general and specific features in the ternary complex and in tRNA.</article-title>
<source><italic>Structure</italic></source>
<volume>7</volume>
<fpage>143</fpage>&#x02013;<lpage>156</lpage>. <pub-id pub-id-type="doi">10.1016/s0969-2126(99)80021-5</pub-id><pub-id pub-id-type="pmid">10368282</pub-id></mixed-citation></ref><ref id="B64"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Novikova</surname><given-names>M.</given-names></name><name><surname>Metlitskaya</surname><given-names>A.</given-names></name><name><surname>Datsenko</surname><given-names>K.</given-names></name><name><surname>Kazakov</surname><given-names>T.</given-names></name><name><surname>Kazakov</surname><given-names>A.</given-names></name><name><surname>Wanner</surname><given-names>B.</given-names></name><etal/></person-group> (<year>2007</year>). <article-title>The <italic>Escherichia coli</italic> Yej transporter is required for the uptake of translation inhibitor microcin C.</article-title>
<source><italic>J. Bacteriol.</italic></source>
<volume>189</volume>
<fpage>8361</fpage>&#x02013;<lpage>8365</lpage>. <pub-id pub-id-type="doi">10.1128/JB.01028-07</pub-id>
<?supplied-pmid 17873039?><pub-id pub-id-type="pmid">17873039</pub-id></mixed-citation></ref><ref id="B65"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Leary</surname><given-names>N. A.</given-names></name><name><surname>Wright</surname><given-names>M. W.</given-names></name><name><surname>Brister</surname><given-names>J. R.</given-names></name><name><surname>Ciufo</surname><given-names>S.</given-names></name><name><surname>Haddad</surname><given-names>D.</given-names></name><name><surname>McVeigh</surname><given-names>R.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Reference sequence (RefSeq) database at NCBI: current status, taxonomic expansion, and functional annotation.</article-title>
<source><italic>Nucleic Acids Res.</italic></source>
<volume>44</volume>
<fpage>D733</fpage>&#x02013;<lpage>D745</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkv1189</pub-id>
<?supplied-pmid 26553804?><pub-id pub-id-type="pmid">26553804</pub-id></mixed-citation></ref><ref id="B66"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Otaka</surname><given-names>T.</given-names></name><name><surname>Kaji</surname><given-names>A.</given-names></name></person-group> (<year>1976</year>). <article-title>Mode of action of bottromycin A2. Release of aminoacyl- or peptidyl-tRNA from ribosomes.</article-title>
<source><italic>J. Biol. Chem.</italic></source>
<volume>251</volume>
<fpage>2299</fpage>&#x02013;<lpage>2306</lpage>.<pub-id pub-id-type="pmid">770464</pub-id></mixed-citation></ref><ref id="B67"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Otaka</surname><given-names>T.</given-names></name><name><surname>Kaji</surname><given-names>A.</given-names></name></person-group> (<year>1981</year>). <article-title>Mode of action of bottromycin A2: effect on peptide bond formation.</article-title>
<source><italic>FEBS Lett.</italic></source>
<volume>123</volume>
<fpage>173</fpage>&#x02013;<lpage>176</lpage>. <pub-id pub-id-type="doi">10.1016/0014-5793(81)80280-3</pub-id><pub-id pub-id-type="pmid">7014241</pub-id></mixed-citation></ref><ref id="B68"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Otaka</surname><given-names>T.</given-names></name><name><surname>Kaji</surname><given-names>A.</given-names></name></person-group> (<year>1983</year>). <article-title>Mode of action of bottromycin A2: effect of bottromycin A2 on polysomes.</article-title>
<source><italic>FEBS Lett.</italic></source>
<volume>153</volume>
<fpage>53</fpage>&#x02013;<lpage>59</lpage>. <pub-id pub-id-type="doi">10.1016/0014-5793(83)80118-5</pub-id><pub-id pub-id-type="pmid">6337880</pub-id></mixed-citation></ref><ref id="B69"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ozaki</surname><given-names>T.</given-names></name><name><surname>Kurokawa</surname><given-names>Y.</given-names></name><name><surname>Hayashi</surname><given-names>S.</given-names></name><name><surname>Oku</surname><given-names>N.</given-names></name><name><surname>Asamizu</surname><given-names>S.</given-names></name><name><surname>Igarashi</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Insights into the Biosynthesis of Dehydroalanines in Goadsporin.</article-title>
<source><italic>Chembiochem</italic></source>
<volume>17</volume>
<fpage>218</fpage>&#x02013;<lpage>223</lpage>. <pub-id pub-id-type="doi">10.1002/cbic.201500541</pub-id>
<?supplied-pmid 26630235?><pub-id pub-id-type="pmid">26630235</pub-id></mixed-citation></ref><ref id="B70"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panter</surname><given-names>F.</given-names></name><name><surname>Krug</surname><given-names>D.</given-names></name><name><surname>Baumann</surname><given-names>S.</given-names></name><name><surname>M&#x000fc;ller</surname><given-names>R.</given-names></name></person-group> (<year>2018</year>). <article-title>Self-resistance guided genome mining uncovers new topoisomerase inhibitors from myxobacteria.</article-title>
<source><italic>Chem. Sci.</italic></source>
<volume>9</volume>
<fpage>4898</fpage>&#x02013;<lpage>4908</lpage>. <pub-id pub-id-type="doi">10.1039/c8sc01325j</pub-id>
<?supplied-pmid 29910943?><pub-id pub-id-type="pmid">29910943</pub-id></mixed-citation></ref><ref id="B71"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parmeggiani</surname><given-names>A.</given-names></name><name><surname>Krab</surname><given-names>I. M.</given-names></name><name><surname>Okamura</surname><given-names>S.</given-names></name><name><surname>Nielsen</surname><given-names>R. C.</given-names></name><name><surname>Nyborg</surname><given-names>J.</given-names></name><name><surname>Nissen</surname><given-names>P.</given-names></name></person-group> (<year>2006</year>). <article-title>Structural basis of the action of pulvomycin and GE2270 A on elongation factor Tu.</article-title>
<source><italic>Biochemistry</italic></source>
<volume>45</volume>
<fpage>6846</fpage>&#x02013;<lpage>6857</lpage>. <pub-id pub-id-type="doi">10.1021/bi0525122</pub-id>
<?supplied-pmid 16734421?><pub-id pub-id-type="pmid">16734421</pub-id></mixed-citation></ref><ref id="B72"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Polikanov</surname><given-names>Y. S.</given-names></name><name><surname>Aleksashin</surname><given-names>N. A.</given-names></name><name><surname>Beckert</surname><given-names>B.</given-names></name><name><surname>Wilson</surname><given-names>D. N.</given-names></name></person-group> (<year>2018</year>). <article-title>The mechanisms of action of ribosome-targeting peptide antibiotics.</article-title>
<source><italic>Front. Mol. Biosci.</italic></source>
<volume>5</volume>:<issue>48</issue>. <pub-id pub-id-type="doi">10.3389/fmolb.2018.00048</pub-id>
<?supplied-pmid 29868608?><pub-id pub-id-type="pmid">29868608</pub-id></mixed-citation></ref><ref id="B73"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Repka</surname><given-names>L. M.</given-names></name><name><surname>Chekan</surname><given-names>J. R.</given-names></name><name><surname>Nair</surname><given-names>S. K.</given-names></name><name><surname>van der Donk</surname><given-names>W.</given-names></name></person-group> (<year>2017</year>). <article-title>Mechanistic understanding of lanthipeptide biosynthetic enzymes.</article-title>
<source><italic>Chem. Rev.</italic></source>
<volume>117</volume>
<fpage>5457</fpage>&#x02013;<lpage>5520</lpage>. <pub-id pub-id-type="doi">10.1021/acs.chemrev.6b00591</pub-id>
<?supplied-pmid 28135077?><pub-id pub-id-type="pmid">28135077</pub-id></mixed-citation></ref><ref id="B74"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodnina</surname><given-names>M. V.</given-names></name><name><surname>Savelsbergh</surname><given-names>A.</given-names></name><name><surname>Matassova</surname><given-names>N. B.</given-names></name><name><surname>Katunin</surname><given-names>V. I.</given-names></name><name><surname>Semenkov</surname><given-names>Y. P.</given-names></name><name><surname>Wintermeyer</surname><given-names>W.</given-names></name></person-group> (<year>1999</year>). <article-title>Thiostrepton inhibits the turnover but not the GTPase of elongation factor G on the ribosome.</article-title>
<source><italic>Proc. Natl. Acad. Sci. U.S.A.</italic></source>
<volume>96</volume>
<fpage>9586</fpage>&#x02013;<lpage>9590</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.96.17.9586</pub-id>
<?supplied-pmid 10449736?><pub-id pub-id-type="pmid">10449736</pub-id></mixed-citation></ref><ref id="B75"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roush</surname><given-names>R. F.</given-names></name><name><surname>Nolan</surname><given-names>E. M.</given-names></name><name><surname>L&#x000f6;hr</surname><given-names>F.</given-names></name><name><surname>Walsh</surname><given-names>C. T.</given-names></name></person-group> (<year>2008</year>). <article-title>Maturation of an <italic>Escherichia coli</italic> ribosomal peptide antibiotic by ATP-consuming N-P bond formation in microcin C7.</article-title>
<source><italic>J. Am. Chem. Soc.</italic></source>
<volume>130</volume>
<fpage>3603</fpage>&#x02013;<lpage>3609</lpage>. <pub-id pub-id-type="doi">10.1021/ja7101949</pub-id>
<?supplied-pmid 18290647?><pub-id pub-id-type="pmid">18290647</pub-id></mixed-citation></ref><ref id="B76"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santos-Aberturas</surname><given-names>J.</given-names></name><name><surname>Chandra</surname><given-names>G.</given-names></name><name><surname>Frattaruolo</surname><given-names>L.</given-names></name><name><surname>Lacret</surname><given-names>R.</given-names></name><name><surname>Pham</surname><given-names>T. H.</given-names></name><name><surname>Vior</surname><given-names>N. M.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Uncovering the unexplored diversity of thioamidated ribosomal peptides in Actinobacteria using the RiPPER genome mining tool.</article-title>
<source><italic>Nucleic Acids Res.</italic></source>
<volume>47</volume>
<fpage>4624</fpage>&#x02013;<lpage>4637</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkz192</pub-id>
<?supplied-pmid 30916321?><pub-id pub-id-type="pmid">30916321</pub-id></mixed-citation></ref><ref id="B77"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schramma</surname><given-names>K. R.</given-names></name><name><surname>Bushin</surname><given-names>L. B.</given-names></name><name><surname>Seyedsayamdost</surname><given-names>M. R.</given-names></name></person-group> (<year>2015</year>). <article-title>Structure and biosynthesis of a macrocyclic peptide containing an unprecedented lysine-to-tryptophan crosslink.</article-title>
<source><italic>Nat. Chem.</italic></source>
<volume>7</volume>
<fpage>431</fpage>&#x02013;<lpage>437</lpage>. <pub-id pub-id-type="doi">10.1038/nchem.2237</pub-id>
<?supplied-pmid 25901822?><pub-id pub-id-type="pmid">25901822</pub-id></mixed-citation></ref><ref id="B78"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwalen</surname><given-names>C. J.</given-names></name><name><surname>Hudson</surname><given-names>G. A.</given-names></name><name><surname>Kille</surname><given-names>B.</given-names></name><name><surname>Mitchell</surname><given-names>D. A.</given-names></name></person-group> (<year>2018</year>). <article-title>Bioinformatic expansion and discovery of thiopeptide antibiotics.</article-title>
<source><italic>J. Am. Chem. Soc.</italic></source>
<volume>140</volume>
<fpage>9494</fpage>&#x02013;<lpage>9501</lpage>. <pub-id pub-id-type="doi">10.1021/jacs.8b03896</pub-id>
<?supplied-pmid 29983054?><pub-id pub-id-type="pmid">29983054</pub-id></mixed-citation></ref><ref id="B79"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwalen</surname><given-names>C. J.</given-names></name><name><surname>Hudson</surname><given-names>G. A.</given-names></name><name><surname>Kosol</surname><given-names>S.</given-names></name><name><surname>Mahanta</surname><given-names>N.</given-names></name><name><surname>Challis</surname><given-names>G. L.</given-names></name><name><surname>Mitchell</surname><given-names>D. A.</given-names></name></person-group> (<year>2017</year>). <article-title>In vitro biosynthetic studies of bottromycin expand the enzymatic capabilities of the YcaO superfamily.</article-title>
<source><italic>J. Am. Chem. Soc.</italic></source>
<volume>139</volume>
<fpage>18154</fpage>&#x02013;<lpage>18157</lpage>. <pub-id pub-id-type="doi">10.1021/jacs.7b09899</pub-id>
<?supplied-pmid 29200283?><pub-id pub-id-type="pmid">29200283</pub-id></mixed-citation></ref><ref id="B80"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Selva</surname><given-names>E.</given-names></name><name><surname>Beretta</surname><given-names>G.</given-names></name><name><surname>Montanini</surname><given-names>N.</given-names></name><name><surname>Saddler</surname><given-names>G. S.</given-names></name><name><surname>Gastaldo</surname><given-names>L.</given-names></name><name><surname>Ferrari</surname><given-names>P.</given-names></name><etal/></person-group> (<year>1991</year>). <article-title>Antibiotic GE2270 a: a novel inhibitor of bacterial protein synthesis. I. isolation and characterization.</article-title>
<source><italic>J. Antibiot.</italic></source>
<volume>44</volume>
<fpage>693</fpage>&#x02013;<lpage>701</lpage>. <pub-id pub-id-type="doi">10.7164/antibiotics.44.693</pub-id>
<?supplied-pmid 1908853?><pub-id pub-id-type="pmid">1908853</pub-id></mixed-citation></ref><ref id="B81"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serebryakova</surname><given-names>M.</given-names></name><name><surname>Tsibulskaya</surname><given-names>D.</given-names></name><name><surname>Mokina</surname><given-names>O.</given-names></name><name><surname>Kulikovsky</surname><given-names>A.</given-names></name><name><surname>Nautiyal</surname><given-names>M.</given-names></name><name><surname>Van Aerschot</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>A trojan-horse peptide-carboxymethyl-cytidine antibiotic from <italic>Bacillus amyloliquefaciens</italic>.</article-title>
<source><italic>J. Am. Chem. Soc.</italic></source>
<volume>138</volume>
<fpage>15690</fpage>&#x02013;<lpage>15698</lpage>. <pub-id pub-id-type="doi">10.1021/jacs.6b09853</pub-id>
<?supplied-pmid 27934031?><pub-id pub-id-type="pmid">27934031</pub-id></mixed-citation></ref><ref id="B82"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shannon</surname><given-names>P.</given-names></name><name><surname>Markiel</surname><given-names>A.</given-names></name><name><surname>Ozier</surname><given-names>O.</given-names></name><name><surname>Baliga</surname><given-names>N. S.</given-names></name><name><surname>Wang</surname><given-names>J. T.</given-names></name><name><surname>Ramage</surname><given-names>D.</given-names></name><etal/></person-group> (<year>2003</year>). <article-title>Cytoscape: a software environment for integrated models of biomolecular interaction networks.</article-title>
<source><italic>Genome Res.</italic></source>
<volume>13</volume>
<fpage>2498</fpage>&#x02013;<lpage>2504</lpage>. <pub-id pub-id-type="doi">10.1101/gr.1239303</pub-id>
<?supplied-pmid 14597658?><pub-id pub-id-type="pmid">14597658</pub-id></mixed-citation></ref><ref id="B83"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shim</surname><given-names>Y. Y.</given-names></name><name><surname>Young</surname><given-names>L. W.</given-names></name><name><surname>Arnison</surname><given-names>P. G.</given-names></name><name><surname>Gilding</surname><given-names>E.</given-names></name><name><surname>Reaney</surname><given-names>M. J. T.</given-names></name></person-group> (<year>2015</year>). <article-title>Proposed systematic nomenclature for orbitides.</article-title>
<source><italic>J. Nat. Prod.</italic></source>
<volume>78</volume>
<fpage>645</fpage>&#x02013;<lpage>652</lpage>. <pub-id pub-id-type="doi">10.1021/np500802p</pub-id>
<?supplied-pmid 25785712?><pub-id pub-id-type="pmid">25785712</pub-id></mixed-citation></ref><ref id="B84"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimamura</surname><given-names>H.</given-names></name><name><surname>Gouda</surname><given-names>H.</given-names></name><name><surname>Nagai</surname><given-names>K.</given-names></name><name><surname>Hirose</surname><given-names>T.</given-names></name><name><surname>Ichioka</surname><given-names>M.</given-names></name><name><surname>Furuya</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>Structure determination and total synthesis of bottromycin A2: a potent antibiotic against MRSA and VRE.</article-title>
<source><italic>Angew. Chemie - Int. Ed.</italic></source>
<volume>48</volume>
<fpage>914</fpage>&#x02013;<lpage>917</lpage>. <pub-id pub-id-type="doi">10.1002/anie.200804138</pub-id>
<?supplied-pmid 19115340?><pub-id pub-id-type="pmid">19115340</pub-id></mixed-citation></ref><ref id="B85"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sikandar</surname><given-names>A.</given-names></name><name><surname>Franz</surname><given-names>L.</given-names></name><name><surname>Melse</surname><given-names>O.</given-names></name><name><surname>Antes</surname><given-names>I.</given-names></name><name><surname>Koehnke</surname><given-names>J.</given-names></name></person-group> (<year>2019</year>). <article-title>Thiazoline-specific amidohydrolase PurAH is the gatekeeper of bottromycin biosynthesis.</article-title>
<source><italic>J. Am. Chem. Soc.</italic></source>
<volume>141</volume>
<fpage>9748</fpage>&#x02013;<lpage>9752</lpage>. <pub-id pub-id-type="doi">10.1021/jacs.8b12231</pub-id>
<?supplied-pmid 31192589?><pub-id pub-id-type="pmid">31192589</pub-id></mixed-citation></ref><ref id="B86"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>S&#x000f6;ding</surname><given-names>J.</given-names></name><name><surname>Biegert</surname><given-names>A.</given-names></name><name><surname>Lupas</surname><given-names>A. N.</given-names></name></person-group> (<year>2005</year>). <article-title>The HHpred interactive server for protein homology detection and structure prediction.</article-title>
<source><italic>Nucleic Acids Res.</italic></source>
<volume>33</volume>
<fpage>W244</fpage>&#x02013;<lpage>W248</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gki408</pub-id>
<?supplied-pmid 15980461?><pub-id pub-id-type="pmid">15980461</pub-id></mixed-citation></ref><ref id="B87"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>S&#x000fc;ssmuth</surname><given-names>R. D.</given-names></name><name><surname>Mainz</surname><given-names>A.</given-names></name></person-group> (<year>2017</year>). <article-title>Nonribosomal peptide synthesis&#x02014;principles and prospects.</article-title>
<source><italic>Angew. Chem. Int. Ed.</italic></source>
<volume>56</volume>
<fpage>3770</fpage>&#x02013;<lpage>3821</lpage>. <pub-id pub-id-type="doi">10.1002/anie.201609079</pub-id>
<?supplied-pmid 28323366?><pub-id pub-id-type="pmid">28323366</pub-id></mixed-citation></ref><ref id="B88"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanaka</surname><given-names>N.</given-names></name><name><surname>Sashikata</surname><given-names>K.</given-names></name><name><surname>Yamaguchi</surname><given-names>H.</given-names></name><name><surname>Umezawa</surname><given-names>H.</given-names></name></person-group> (<year>1966</year>). <article-title>Inhibition of protein synthesis by bottromycin A2 and its hydrazide.</article-title>
<source><italic>J. Biochem.</italic></source>
<volume>60</volume>
<fpage>405</fpage>&#x02013;<lpage>410</lpage>. <pub-id pub-id-type="doi">10.1093/oxfordjournals.jbchem.a128451</pub-id>
<?supplied-pmid 5339116?><pub-id pub-id-type="pmid">5339116</pub-id></mixed-citation></ref><ref id="B89"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tietz</surname><given-names>J. I. T.</given-names></name><name><surname>Schwalen</surname><given-names>C. J.</given-names></name><name><surname>Patel</surname><given-names>P. S.</given-names></name><name><surname>Maxon</surname><given-names>T.</given-names></name><name><surname>Blair</surname><given-names>P. M.</given-names></name><name><surname>Tai</surname><given-names>H.-C.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>A new genome mining tool redefines the lasso peptide biosynthetic landscape.</article-title>
<source><italic>Nat. Chem. Biol.</italic></source>
<volume>13</volume>
<fpage>470</fpage>&#x02013;<lpage>478</lpage>. <pub-id pub-id-type="doi">10.1038/nchembio.2319</pub-id>
<?supplied-pmid 28244986?><pub-id pub-id-type="pmid">28244986</pub-id></mixed-citation></ref><ref id="B90"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Travin</surname><given-names>D. Y.</given-names></name><name><surname>Metelev</surname><given-names>M.</given-names></name><name><surname>Serebryakova</surname><given-names>M.</given-names></name><name><surname>Komarova</surname><given-names>E. S.</given-names></name><name><surname>Osterman</surname><given-names>I. A.</given-names></name><name><surname>Ghilarov</surname><given-names>D.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Biosynthesis of translation inhibitor klebsazolicin proceeds through heterocyclization and n-terminal amidine formation catalyzed by a single YcaO enzyme.</article-title>
<source><italic>J. Am. Chem. Soc.</italic></source>
<volume>140</volume>
<fpage>5625</fpage>&#x02013;<lpage>5633</lpage>. <pub-id pub-id-type="doi">10.1021/jacs.8b02277</pub-id>
<?supplied-pmid 29601195?><pub-id pub-id-type="pmid">29601195</pub-id></mixed-citation></ref><ref id="B91"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Travin</surname><given-names>D. Y.</given-names></name><name><surname>Watson</surname><given-names>Z. L.</given-names></name><name><surname>Metelev</surname><given-names>M.</given-names></name><name><surname>Ward</surname><given-names>F. R.</given-names></name><name><surname>Osterman</surname><given-names>I. A.</given-names></name><name><surname>Khven</surname><given-names>I. M.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Structure of ribosome-bound azole-modified peptide phazolicin rationalizes its species-specific mode of bacterial translation inhibition.</article-title>
<source><italic>Nat. Commun.</italic></source>
<volume>10</volume>:<issue>4563</issue>. <pub-id pub-id-type="doi">10.1038/s41467-019-12589-5</pub-id>
<?supplied-pmid 31594941?><pub-id pub-id-type="pmid">31594941</pub-id></mixed-citation></ref><ref id="B92"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsibulskaya</surname><given-names>D.</given-names></name><name><surname>Mokina</surname><given-names>O.</given-names></name><name><surname>Kulikovsky</surname><given-names>A.</given-names></name><name><surname>Piskunova</surname><given-names>J.</given-names></name><name><surname>Severinov</surname><given-names>K.</given-names></name><name><surname>Serebryakova</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>The product of <italic>Yersinia pseudotuberculosis</italic> mcc operon is a peptide-cytidine antibiotic activated inside producing cells by the tldd/e protease.</article-title>
<source><italic>J. Am. Chem. Soc.</italic></source>
<volume>139</volume>
<fpage>16178</fpage>&#x02013;<lpage>16187</lpage>. <pub-id pub-id-type="doi">10.1021/jacs.7b07118</pub-id>
<?supplied-pmid 29045133?><pub-id pub-id-type="pmid">29045133</pub-id></mixed-citation></ref><ref id="B93"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vetting</surname><given-names>M. W.</given-names></name><name><surname>Hegde</surname><given-names>S. S.</given-names></name><name><surname>Wang</surname><given-names>M.</given-names></name><name><surname>Jacoby</surname><given-names>G.</given-names></name><name><surname>Hooper</surname><given-names>D. C.</given-names></name><name><surname>Blanchard</surname><given-names>J. S.</given-names></name></person-group> (<year>2011</year>). <article-title>Structure of QnrB1, a plasmid-mediated fluoroquinolone resistance factor.</article-title>
<source><italic>J. Biol. Chem.</italic></source>
<volume>286</volume>
<fpage>25265</fpage>&#x02013;<lpage>25273</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M111.226936</pub-id>
<?supplied-pmid 21597116?><pub-id pub-id-type="pmid">21597116</pub-id></mixed-citation></ref><ref id="B94"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waisvisz</surname><given-names>J. M.</given-names></name><name><surname>van der Hoeven</surname><given-names>M. G.</given-names></name><name><surname>van Peppen</surname><given-names>J.</given-names></name><name><surname>Zwennis</surname><given-names>W. C. M.</given-names></name></person-group> (<year>1957</year>). <article-title>Bottromycin. I. a new sulfur-containing antibiotic.</article-title>
<source><italic>J. Am. Chem. Soc.</italic></source>
<volume>79</volume>
<fpage>4520</fpage>&#x02013;<lpage>4521</lpage>. <pub-id pub-id-type="doi">10.1021/ja01573a072</pub-id></mixed-citation></ref><ref id="B95"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>D. N.</given-names></name></person-group> (<year>2014</year>). <article-title>Ribosome-targeting antibiotics and mechanisms of bacterial resistance.</article-title>
<source><italic>Nat. Rev. Microbiol.</italic></source>
<volume>12</volume>
<fpage>35</fpage>&#x02013;<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1038/nrmicro3155</pub-id>
<?supplied-pmid 24336183?><pub-id pub-id-type="pmid">24336183</pub-id></mixed-citation></ref><ref id="B96"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wright</surname><given-names>G. D.</given-names></name></person-group> (<year>2017</year>). <article-title>Opportunities for natural products in 21st century antibiotic discovery.</article-title>
<source><italic>Nat. Prod. Rep.</italic></source>
<volume>34</volume>
<fpage>694</fpage>&#x02013;<lpage>701</lpage>. <pub-id pub-id-type="doi">10.1039/c7np00019g</pub-id>
<?supplied-pmid 28569300?><pub-id pub-id-type="pmid">28569300</pub-id></mixed-citation></ref><ref id="B97"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Young</surname><given-names>T. S.</given-names></name><name><surname>Dorrestein</surname><given-names>P. C.</given-names></name><name><surname>Walsh</surname><given-names>C. T.</given-names></name></person-group> (<year>2012</year>). <article-title>Codon randomization for rapid exploration of chemical space in thiopeptide antibiotic variants.</article-title>
<source><italic>Chem. Biol.</italic></source>
<volume>19</volume>
<fpage>1600</fpage>&#x02013;<lpage>1610</lpage>. <pub-id pub-id-type="doi">10.1016/j.chembiol.2012.10.013</pub-id>
<?supplied-pmid 23261603?><pub-id pub-id-type="pmid">23261603</pub-id></mixed-citation></ref><ref id="B98"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>Q.</given-names></name><name><surname>Fang</surname><given-names>H.</given-names></name><name><surname>Liu</surname><given-names>W.</given-names></name></person-group> (<year>2017</year>). <article-title>Post-translational modifications involved in the biosynthesis of thiopeptide antibiotics.</article-title>
<source><italic>Org. Biomol. Chem.</italic></source>
<volume>15</volume>
<fpage>3376</fpage>&#x02013;<lpage>3390</lpage>. <pub-id pub-id-type="doi">10.1039/c7ob00466d</pub-id>
<?supplied-pmid 28358161?><pub-id pub-id-type="pmid">28358161</pub-id></mixed-citation></ref><ref id="B99"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ziemert</surname><given-names>N.</given-names></name><name><surname>Alanjary</surname><given-names>M.</given-names></name><name><surname>Weber</surname><given-names>T.</given-names></name></person-group> (<year>2016</year>). <article-title>The evolution of genome mining in microbes - a review.</article-title>
<source><italic>Nat. Prod. Rep.</italic></source>
<volume>33</volume>
<fpage>988</fpage>&#x02013;<lpage>1005</lpage>. <pub-id pub-id-type="doi">10.1039/c6np00025h</pub-id>
<?supplied-pmid 27272205?><pub-id pub-id-type="pmid">27272205</pub-id></mixed-citation></ref></ref-list></back></article>